image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
51889e31e0a61ee06fb1e141dbfc9c455b76bda1c7ce5217af0bf9a76cf7826f.png | simple | <table><tr><td>Group</td><td>Number of subjects</td><td>M/F</td><td>Age</td></tr><tr><td>Low SES</td><td>25</td><td>14/11</td><td>24.4 ± 1.2</td></tr><tr><td>Mid SES</td><td>27</td><td>14/13</td><td>23.1 ± 1.2</td></tr></table> |
4d7ab21afd8689181233b87ad554a875e664aadc2a896c8c62fe89f61a292426.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">MCHC Physicians</td><td colspan="2">Non-MCHC Physicians</td><td colspan="2">Nurses</td><td colspan="2">Parents</td></tr><tr><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>Physical Examination</td><td>86/94</td><td>91.5</td><td>129/146</td><td>88.4</td><td>137/148</td><td>92.6</td><td>923/1050</td><td>87.9</td></tr><tr><td>Detection of Abnormal Health Conditions</td><td>77/93</td><td>82.8</td><td>124/147</td><td>84.4</td><td>130/148</td><td>87.8</td><td>981/1049</td><td><i>93.5</i>*</td></tr><tr><td>Developmental Screening</td><td>79/94</td><td>84</td><td>126/145</td><td>86.9</td><td>94/148</td><td><i>63.5</i>**</td><td>876/1050</td><td>83.4</td></tr><tr><td>Anticipatory Guidance</td><td>73/94</td><td>77.7</td><td>104/145</td><td>71.7</td><td>68/146</td><td><i>46.6**</i></td><td>312/1050</td><td><i>29.7*</i>*</td></tr><tr><td>Parent-child interaction counseling</td><td>70/93</td><td>75.3</td><td>95/145</td><td>65.5</td><td>60/144</td><td><i>41.7</i>**</td><td>235/1050</td><td><i>22.4**</i></td></tr><tr><td>Consultant for MCHC Staff</td><td>70/94</td><td>74.5</td><td>125/147</td><td>85</td><td>110/147</td><td>74.8</td><td>602/1048</td><td><i>57.4</i>**</td></tr><tr><td>Detection of Children at Risk</td><td>71/92</td><td>77.2</td><td>121/143</td><td><i>84.6</i>*</td><td>104/148</td><td>70.3</td><td>749/1050</td><td>71.3</td></tr><tr><td>Growth Surveillance</td><td>69/93</td><td>74.2</td><td>121/146</td><td>82.9</td><td>61/146</td><td><i>41.8</i>**</td><td>426/1050</td><td><i>40.6</i>**</td></tr><tr><td>Vaccination Counseling</td><td>57/93</td><td>61.3</td><td>123/145</td><td>84.8</td><td>50/145</td><td><i>34.5*</i>*</td><td>358/1050</td><td><i>34.1</i>**</td></tr><tr><td>Primary Care Physician Communication</td><td>36/90</td><td><i>40</i>**</td><td>108/146</td><td>74</td><td>92/148</td><td>62.2</td><td>737/1050</td><td>70.2</td></tr></table> |
3f0c6431815113b21449b73c9c99a8534643c8eab774c6ad85675401aa0d61f8.png | complex | <table><tr><td>Proposal ingredient</td><td>Key question</td><td>Review criteria</td><td>Check (yes/no)</td></tr><tr><td>1. The care gap or quality gap</td><td>The proposal has clear evidence that a gap in quality exists?</td><td>Significance Impact</td><td> </td></tr><tr><td>2. The evidence-based treatment to be implemented</td><td>Is the evidence for the program, treatment, or set of services to be implemented demonstrated?</td><td>Significance Innovation</td><td> </td></tr><tr><td>3. Conceptual model and theoretical justification</td><td>The proposal delineates a clear conceptual framework/theory/model that informs the design and variables being tested?</td><td>Approach Innovation</td><td> </td></tr><tr><td>4. Stakeholder priorities, engagement in change</td><td>Is there a clear engagement process of the stakeholders in place?</td><td>Significance Impact Approach Environment</td><td> </td></tr><tr><td>5. Setting’s readiness to adopt new services/treatments/programs</td><td>Is there clear information that reflects the setting’s readiness, capacity, or appetite for change, specifically around adoption of the proposed evidence-based treatment?</td><td>Impact Approach Environment</td><td> </td></tr><tr><td>6. Implementation strategy/process</td><td>Are the strategies to implement the intervention clearly defined, and justified conceptually?</td><td>Significance Impact Innovation</td><td> </td></tr><tr><td>7. Team experience with the setting, treatment, implementation process</td><td>Does the proposal detail the team’s experience with the study setting, the treatment whose implementation is being studied, and implementation processes?</td><td>Approach Investigator team</td><td> </td></tr><tr><td>8. Feasibility of proposed research design and methods</td><td>Does the methods section contain as much detail as possible, as well as lay out possible choice junctures and contingencies, should methods not work as planned?</td><td>Approach Investigator team</td><td> </td></tr><tr><td rowspan="3">9. Measurement and analysis section</td><td>Does the proposal clarify the key constructs to be measured, corresponding to the overarching conceptual model or theory?</td><td rowspan="3">Approach Investigator team</td><td rowspan="3"> </td></tr><tr><td>Is a measurement plan clear for each construct?</td></tr><tr><td>Does the analysis section demonstrate how relationships between constructs will be tested?</td></tr><tr><td>10. Policy/funding environment; leverage or support for sustaining change</td><td>Does the proposal address how the implementation initiative aligns with policy trends?</td><td>Impact Significance</td><td> </td></tr></table> |
9db95f7a782189d4302117627d38697b88d945e0a142182beb7bd9545e590b33.png | complex | <table><tr><td></td><td colspan="2">WCST Error Score</td></tr><tr><td></td><td>Component 1</td><td>Component 2</td></tr><tr><td></td><td>(7.4% Variance)</td><td>(6.5% Variance)</td></tr><tr><td>Age</td><td>0.391</td><td></td></tr><tr><td>Education</td><td>−0.538</td><td></td></tr><tr><td>Income</td><td>−0.295</td><td></td></tr><tr><td>Proficiency L1</td><td>−0.283</td><td></td></tr><tr><td>Open to experiences</td><td>−0.258</td><td></td></tr><tr><td>QoL</td><td></td><td>0.437</td></tr><tr><td>Attitude L3</td><td></td><td>0.436</td></tr><tr><td>Emotional stability</td><td></td><td>0.280</td></tr></table> |
683ee455820f8dbcb6bfa52625948beac22692350aab9e4c4eaf7a23fe05e6f5.png | complex | <table><tr><td>Independent variables</td><td>Non-working</td><td>Irregular employees</td><td>Regular employees</td></tr><tr><td colspan="4">Age and Marital status</td></tr><tr><td rowspan="2">Age</td><td>0.0187</td><td>0.0269**</td><td>−0.006</td></tr><tr><td>(0.0129)</td><td>(0.0126)</td><td>(0.0169)</td></tr><tr><td rowspan="2">Married</td><td>−0.349***</td><td>0.0361</td><td>−0.0957</td></tr><tr><td>(0.101)</td><td>(0.104)</td><td>(0.148)</td></tr><tr><td colspan="4">Educational attainment</td></tr><tr><td rowspan="2">Junior high school</td><td>−0.00893</td><td>−0.101</td><td>0.0893</td></tr><tr><td>(0.106)</td><td>(0.108)</td><td>(0.151)</td></tr><tr><td rowspan="2">Vocational school</td><td>−0.0298</td><td>0.190*</td><td>−0.0753</td></tr><tr><td>(0.111)</td><td>(0.114)</td><td>(0.150)</td></tr><tr><td rowspan="2">Junior college or technical college</td><td>0.121</td><td>0.0536</td><td>−0.120</td></tr><tr><td>(0.0921)</td><td>(0.107)</td><td>(0.156)</td></tr><tr><td rowspan="2">University</td><td>−0.0657</td><td>−0.0973</td><td>−0.157</td></tr><tr><td>(0.106)</td><td>(0.0986)</td><td>(0.105)</td></tr><tr><td rowspan="2">Graduate school</td><td>−0.145</td><td>0.000837</td><td>0.284</td></tr><tr><td>(0.513)</td><td>(0.388)</td><td>(0.302)</td></tr><tr><td colspan="4">Residence</td></tr><tr><td rowspan="2">Rental housing</td><td>0.0491</td><td>0.227*</td><td>0.197</td></tr><tr><td>(0.137)</td><td>(0.121)</td><td>(0.163)</td></tr><tr><td rowspan="2">Company residence</td><td>−0.371</td><td>0.560</td><td>0.254</td></tr><tr><td>(0.522)</td><td>(0.425)</td><td>(0.450)</td></tr><tr><td rowspan="2">Other residences</td><td>−0.169</td><td>0.357</td><td>0.510</td></tr><tr><td>(0.263)</td><td>(0.225)</td><td>(0.335)</td></tr><tr><td colspan="4">Health status and Medical care use</td></tr><tr><td rowspan="2">Diabetes</td><td>−0.0372</td><td>−0.151</td><td>−0.0755</td></tr><tr><td>(0.122)</td><td>(0.125)</td><td>(0.148)</td></tr><tr><td rowspan="2">Heart disease</td><td>0.0851</td><td>0.0306</td><td>0.320*</td></tr><tr><td>(0.166)</td><td>(0.167)</td><td>(0.187)</td></tr><tr><td rowspan="2">Cerebral stroke</td><td>0.0890</td><td>0.203</td><td>−0.681</td></tr><tr><td>(0.222)</td><td>(0.259)</td><td>(0.545)</td></tr><tr><td rowspan="2">Cancer</td><td>−0.0948</td><td>−0.00433</td><td>0.435</td></tr><tr><td>(0.212)</td><td>(0.238)</td><td>(0.300)</td></tr><tr><td rowspan="2">Having friend/acquaintances</td><td>−0.0823</td><td>0.0586</td><td>0.121</td></tr><tr><td>(0.0867)</td><td>(0.103)</td><td>(0.122)</td></tr></table> |
26759f96f0ad58fcb90e6cea1d3834c51c6d722f356e607b48b2616bd2c8b298.png | complex | <table><tr><td>GO biological process terms</td><td>p-value</td><td>GO biological process terms</td><td>p-value</td></tr><tr><td colspan="4">Genes up-regulated in erythroblasts</td></tr><tr><td>heme biosynthesis</td><td>8.3593E-09</td><td>tRNA metabolism</td><td>4.7686E-04</td></tr><tr><td>heme metabolism</td><td>4.1178E-08</td><td>nitrogen compound metabolism</td><td>0.0011</td></tr><tr><td>pigment biosynthesis</td><td>7.8243E-08</td><td>cholesterol biosynthesis</td><td>0.0021</td></tr><tr><td>porphyrin biosynthesis</td><td>8.0158E-08</td><td>amino acid activation</td><td>0.0022</td></tr><tr><td>pigment metabolism</td><td>1.8805E-07</td><td>tRNA aminoacylation for protein translation</td><td>0.0022</td></tr><tr><td>porphyrin metabolism</td><td>2.5313E-07</td><td>tRNA aminoacylation</td><td>0.0022</td></tr><tr><td>carboxylic acid metabolism</td><td>3.5431E-07</td><td>electron transport</td><td>0.0023</td></tr><tr><td>organic acid metabolism</td><td>4.0819E-07</td><td>amino acid and derivative metabolism</td><td>0.0025</td></tr><tr><td>secondary metabolism</td><td>5.8601E-07</td><td>amine metabolism</td><td>0.0037</td></tr><tr><td>heterocycle metabolism</td><td>4.7133E-06</td><td>lipid metabolism</td><td>0.0037</td></tr><tr><td>cellular biosynthesis</td><td>6.9372E-06</td><td>steroid biosynthesis</td><td>0.0041</td></tr><tr><td>cofactor metabolism</td><td>1.0534E-05</td><td>cholesterol metabolism</td><td>0.0041</td></tr><tr><td>cofactor biosynthesis</td><td>1.9914E-05</td><td>iron ion homeostasis</td><td>0.0042</td></tr><tr><td>generation of precursor metabolites and energy</td><td>3.9831E-05</td><td>sterol biosynthesis</td><td>0.0045</td></tr><tr><td>cellular metabolism</td><td>5.6290E-05</td><td>mitotic cell cycle</td><td>0.0059</td></tr><tr><td>lipid biosynthesis</td><td>1.6546E-04</td><td>alcohol metabolism</td><td>0.0060</td></tr><tr><td>cellular lipid metabolism</td><td>2.3765E-04</td><td>sterol metabolism</td><td>0.0061</td></tr><tr><td>amino acid metabolism</td><td>4.3568E-04</td><td></td><td></td></tr><tr><td colspan="4">Genes up-regulated in megakaryoblasts</td></tr><tr><td>hemostasis</td><td>0.0010</td><td>positive regulation of cell proliferation</td><td>0.0024</td></tr><tr><td>endocytosis</td><td>0.0011</td><td>steroid metabolism</td><td>0.0024</td></tr><tr><td>cellular lipid metabolism</td><td>0.0012</td><td>lipid biosynthesis</td><td>0.0026</td></tr><tr><td>wound healing</td><td>0.0014</td><td>regulation of receptor mediated endocytosis</td><td>0.0034</td></tr><tr><td>lipid metabolism</td><td>0.0020</td><td>localization of cell</td><td>0.0049</td></tr><tr><td>alcohol metabolism</td><td>0.0020</td><td>cell motility</td><td>0.0049</td></tr><tr><td>regulation of body fluids</td><td>0.0024</td><td>cytoskeleton organization and biogenesis</td><td>0.0081</td></tr><tr><td>transport</td><td>0.0024</td><td>cholesterol biosynthesis</td><td>0.0089</td></tr><tr><td colspan="4">Genes up-regulated in monoblasts</td></tr><tr><td>response to biotic stimulus</td><td>6.3071E-15</td><td>antimicrobial humoral response</td><td>3.1669E-04</td></tr><tr><td>immune response</td><td>2.8466E-13</td><td>detection of stimulus</td><td>6.8750E-04</td></tr><tr><td>defense response</td><td>7.3698E-13</td><td>protein kinase cascade</td><td>0.0010</td></tr><tr><td>response to pest, pathogen or parasite</td><td>1.2074E-12</td><td>wound healing</td><td>0.0014</td></tr><tr><td>response to other organism</td><td>2.4524E-12</td><td>intracellular signaling cascade</td><td>0.0017</td></tr><tr><td>response to external stimulus</td><td>1.0443E-10</td><td>positive regulation of cellular process</td><td>0.0017</td></tr><tr><td>response to stimulus</td><td>8.1038E-10</td><td>endocytosis</td><td>0.0019</td></tr><tr><td>response to wounding</td><td>1.3630E-09</td><td>I-kappaB kinase/NF-kappaB cascade</td><td>0.0025</td></tr><tr><td>response to stress</td><td>2.1560E-08</td><td>lymphocyte activation</td><td>0.0031</td></tr><tr><td>inflammatory response</td><td>3.0602E-08</td><td>blood coagulation</td><td>0.0034</td></tr><tr><td>cell communication</td><td>5.0323E-07</td><td>taxis</td><td>0.0035</td></tr><tr><td>signal transduction</td><td>7.7480E-07</td><td>chemotaxis</td><td>0.0035</td></tr><tr><td>organismal physiological process</td><td>8.0044E-07</td><td>innate immune response</td><td>0.0037</td></tr><tr><td>response to pathogen</td><td>3.1842E-06</td><td>coagulation</td><td>0.0038</td></tr><tr><td>humoral immune response</td><td>3.4723E-05</td><td>locomotory behavior</td><td>0.0044</td></tr><tr><td>detection of biotic stimulus</td><td>4.6946E-05</td><td>hemostasis</td><td>0.0045</td></tr><tr><td>response to bacteria</td><td>6.7200E-05</td><td>carbohydrate metabolism</td><td>0.0048</td></tr><tr><td>response to pathogenic bacteria</td><td>9.7266E-05</td><td>cell surface receptor linked signal transduction</td><td>0.0059</td></tr><tr><td>immune cell activation</td><td>1.0815E-04</td><td>positive regulation of biological process</td><td>0.0064</td></tr><tr><td>cell activation</td><td>1.2116E-04</td><td>macrophage activation</td><td>0.0093</td></tr><tr><td>humoral defense mechanism (sensu Vertebrata)</td><td>1.4837E-04</td><td>regulation of body fluids</td><td>0.0097</td></tr><tr><td>antimicrobial humoral response (sensu Vertebrata)</td><td>2.8361E-04</td><td></td><td></td></tr><tr><td colspan="4">Genes up-regulated in myeloblasts</td></tr><tr><td>carboxylic acid metabolism</td><td>2.2728E-05</td><td>defense response</td><td>0.0018</td></tr><tr><td>organic acid metabolism</td><td>2.3815E-05</td><td>response to biotic stimulus</td><td>0.0025</td></tr><tr><td>cellular biosynthesis</td><td>7.1605E-04</td><td>immune response</td><td>0.0048</td></tr><tr><td>biosynthesis</td><td>0.0016</td><td>positive regulation of cell proliferation</td><td>0.0069</td></tr></table> |
ebe0fec985d878bccb29db8bece0d40347fd998e396be3941d1191a1700e02ce.png | simple | <table><tr><td>Peaks</td><td>Human</td><td>Yeast</td><td>Random</td></tr><tr><td>1</td><td>0.246</td><td>0.218</td><td>0.402</td></tr><tr><td>2</td><td>0.213</td><td>0.168</td><td>0.320</td></tr><tr><td>3</td><td>0.188</td><td>0.151</td><td>0.269</td></tr></table> |
7059a88118705566411fb30c22d7cd460e970156986837519e84fe231fc44f0d.png | simple | <table><tr><td></td><td>Gene3D</td><td>Pfam</td><td>Panther</td><td>SeqF_95</td><td>SeqF_99</td><td>SeqF_100</td></tr><tr><td>True positive sensitivity</td><td>0.998</td><td>0.937</td><td>0.919</td><td>0.862</td><td>0.821</td><td>0.492</td></tr><tr><td>False negative sensitivity</td><td>0.907</td><td>0.704</td><td>0.532</td><td>0.831</td><td>0.775</td><td>0.282</td></tr><tr><td>Overall (TP + FN) sensitivity</td><td>0.983</td><td>0.898</td><td>0.831</td><td>0.857</td><td>0.814</td><td>0.457</td></tr><tr><td>(False positive) specificity</td><td>0.854</td><td>1.000</td><td>-</td><td>0.452</td><td>0.603</td><td>0.973</td></tr><tr><td>Positive predictive value</td><td>0.990</td><td>1.000</td><td>-</td><td>0.948</td><td>0.960</td><td>0.995</td></tr><tr><td>Sensitivity at <35% seq-ID</td><td>0.925</td><td>0.761</td><td>0.639</td><td>0.769</td><td>0.699</td><td>0.316</td></tr><tr><td>Sensitivity at <30% seq-ID</td><td>0.869</td><td>0.738</td><td>0.618</td><td>0.869</td><td>0.783</td><td>0.400</td></tr><tr><td>Sensitivity at <25% seq-ID</td><td>0.600</td><td>0.467</td><td>0.250</td><td>0.933</td><td>0.786</td><td>0.429</td></tr></table> |
511586db1ac929c1b44710b86eff8dda8d2b0f2861614fba4a70588cf1f9a027.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">SD</td><td colspan="2">SD + Chol (0.25 %)</td><td colspan="2">HF + Chol (0.25 %)</td></tr><tr><td>Sham</td><td>Ovx</td><td>Sham</td><td>Ovx</td><td>Sham</td><td>Ovx</td></tr><tr><td>Final body weight (g)</td><td>353.9 ± 11.3</td><td>439.6 ± 14.5***</td><td>347.5 ± 8.7</td><td>431.6 ± 25.7***</td><td>391.6 ± 13.7</td><td>467.4 ± 15.6***</td></tr><tr><td>Intra-abdominal fat pad weights (g)</td><td>29.2 ± 4.4</td><td>39.3 ± 3.7**</td><td>26.6 ± 2.6</td><td>40.2 ± 4.9**</td><td>38.7 ± 3.8</td><td>43.8 ± 2.6**</td></tr><tr><td>Food intake (kcal/day)</td><td>82.7 ± 4.3</td><td>99.8 ± 4.2***</td><td>81 ± 2.5</td><td>95.7 ± 7.0***</td><td>94.9 ± 4.7<sup>†δ</sup></td><td>110.1 ± 4.2***<sup>†δ</sup></td></tr><tr><td>Uterus (g)</td><td>0.50 ± 0.03</td><td>0.10 ± 0.01***</td><td>0.51 ± 0.07</td><td>0.10 ± 0.01***</td><td>0.47 ± 0.05</td><td>0.11 ± 0.01***</td></tr></table> |
9c48e5ec57b7d1918db817ecfa630581c1990660806b2071994317c4f8f7bc3b.png | simple | <table><tr><td>AGRF ID</td><td>GenBank Accession</td><td>UniGene Cluster</td><td>Gene</td><td>Fold Change</td><td>P Value</td></tr><tr><td>H3084H06</td><td>BG070211</td><td>Mm.25335</td><td>EST: Cdc14b: CDC14 cell division cycle 14 homolog B (S. cerevisiae)</td><td>+ 3.1</td><td>0.044</td></tr><tr><td>H3137G08</td><td>BG074662</td><td>Mm.197274</td><td>EST: Moderately similar to GNMSLL retrovirus-related reverse transcriptase homolog – mouse retrotransposon (M. musculus)</td><td>+ 3.0</td><td>0.046</td></tr><tr><td>H3123E03</td><td>BG073512</td><td>Mm.197252</td><td>EST: Weakly similar to TLM MOUSE TLM PROTEIN (M. musculus)</td><td>+ 2.9</td><td>0.047</td></tr><tr><td>H3073G12</td><td>BG069200</td><td>Mm.328026</td><td>EST: Transcribed sequence with moderate similarity to protein ref:NP_083358.1 (M. musculus); RIKEN cDNA 5830411J07</td><td>+ 2.5</td><td>0.038</td></tr><tr><td>H3082G05</td><td>AU014577</td><td>Not assigned</td><td>EST</td><td>+ 2.1</td><td>0.032</td></tr></table> |
d266798cf0d817ded49afa421b60716b55381346d1fc7a6698e6ff55827f2cdc.png | complex | <table><tr><td></td><td>Mean (SD)</td></tr><tr><td>Age</td><td>43.7 (9.9) years</td></tr><tr><td>Gender</td><td>11 males, 12 females</td></tr><tr><td>Center-edge angle</td><td>33.7 (7.8)°</td></tr><tr><td>Alpha angle</td><td>73 (9.6)° (all alpha angles were 55° or greater)</td></tr><tr><td>Loose bodies visible on radiographs</td><td>5 (23.8%)</td></tr><tr><td>Loose bodies visible on MRI</td><td>14 (66.6%)</td></tr><tr><td rowspan="3">Tonnis grade</td><td>Grade 0 in 14 patients (66.6%)</td></tr><tr><td>Grade 1 in 7 patients (28.5%)</td></tr><tr><td>Grade 2 in one (4%)</td></tr></table> |
417f7a35851ebb77db13912f6de9ffdd0816d09661dcaa160d158b01d095f228.png | complex | <table><tr><td rowspan="2"> </td><td>Without allergy</td><td>With allergy</td><td rowspan="2"><i>P-value</i></td></tr><tr><td>(n = 387)</td><td>(n = 18)</td></tr><tr><td colspan="4">Boys</td></tr><tr><td>Age</td><td>12.44 ± 2.62</td><td>12.25 ± 3.33</td><td>0.056*</td></tr><tr><td>Height</td><td>141.76 ± 16.24</td><td>147.59 ± 16.44</td><td>0.229</td></tr><tr><td>Weight</td><td>35.54 ± 10.25</td><td>37.53 ± 12.46</td><td>0.519</td></tr><tr><td>HAZ</td><td>−1.43 ± 1.21</td><td>−0.52 ± 0.96</td><td>0.011*</td></tr><tr><td>WAZ</td><td>−1.26 ± 1.03</td><td>−0.85 ± 0.82</td><td>0.176</td></tr><tr><td>BMIZ</td><td>−0.61 ± 1.27</td><td>−0.88 ± 0.87</td><td>0.460</td></tr><tr><td>Parasitic infection</td><td>0.21 ± 0.41</td><td>0.42 ± 0.51</td><td>0.102</td></tr><tr><td>Total IgE (IU/ml)</td><td>1809.59 ± 3037.425</td><td>1257.00 ± 1212.94</td><td>0.690</td></tr><tr><td colspan="4">Girls</td></tr><tr><td>Age</td><td>11.72 ± 2.25</td><td>14.00 ± 4.00</td><td>0.019*</td></tr><tr><td>Height</td><td>138.83 ± 13.28</td><td>142.67 ± 15.11</td><td>0.490</td></tr><tr><td>Weight</td><td>34.96 ± 9.15</td><td>40.58 ± 17.37</td><td>0.154</td></tr><tr><td>HAZ</td><td>−1.35 ± 1.40</td><td>−1.63 ± 0.58</td><td>0.637</td></tr><tr><td>WAZ</td><td>−0.89 ± 1.00</td><td>−1.06 ± 1.21</td><td>0.676</td></tr><tr><td>BMIZ</td><td>−0.27 ± 1.43</td><td>−0.32 ± 1.01</td><td>0.941</td></tr><tr><td>Parasitic infection</td><td>0.23 ± 0.42</td><td>0.33 ± 0.52</td><td>0.543</td></tr><tr><td>Total IgE (IU/ml)</td><td>2000.98 ± 3127.71</td><td>1267.67 ± 1793.02</td><td>0.692</td></tr></table> |
9ded26b9c64c6f0fefab34eb6969a23e496f332e607945015bd496b9058bf706.png | simple | <table><tr><td>Group</td><td>At surgery</td><td>At 8 weeks</td><td>ISQ change</td></tr><tr><td>Control</td><td>46.83 ± 3.97</td><td>60.17 ± 3.25</td><td>13.33 ± 5.43</td></tr><tr><td>0.1</td><td>48.00 ± 4.00</td><td>64.83 ± 3.19</td><td>16.83 ± 4.67</td></tr><tr><td>0.5</td><td>49.83 ± 5.95</td><td>71.67 ± 6.15</td><td>19.83 ± 9.56</td></tr><tr><td>1.0</td><td>52.67 ± 7.61</td><td>72.00 ± 2.68</td><td>18.17 ± 6.94</td></tr></table> |
5def3b31176a669c1700a3ab81eb4460f12cc155da2a18c292a206c91f298955.png | complex | <table><tr><td>Period</td><td>Activity</td><td>Who involved</td></tr><tr><td rowspan="2">Month 1</td><td rowspan="2">Consultation and sensitisation of Kilifi District stakeholders</td><td>1. MoH structure: District Medical Officer of Health and District Health Management Team at Kilifi District Hospital. All health facility in-charges working in Kilifi District</td></tr><tr><td>2. Provincial administration structures: District Commissioner, Senior District Officer, all chiefs working in Kilifi District</td></tr><tr><td rowspan="3">Months 2 to 6</td><td rowspan="3">Community entry and sensitisation of stakeholders in sites A, B and C respectively</td><td>1. MoH Structure: Dispensary health committees, dispensary staff (facility in-charges, nurses, public health officers, community health extension workers), and community health workers (CHWs)</td></tr><tr><td>2. Local administration: District officers, local (assistant) chiefs and village elders</td></tr><tr><td>3. Others: primary school head teachers, religious leaders, a local District Stakeholders Forum</td></tr><tr><td>Months 8 to 13</td><td>Identification and recruitment of 5 to 17 month-old children (n = 600)</td><td>CHWs and fieldworkers</td></tr><tr><td>Months 15 to 27</td><td>Identification and recruitment of 6 to 12 week-old children (n = 304)</td><td>CHWs and fieldworkers</td></tr><tr><td rowspan="3">From month 8 to date</td><td>Follow-up of research participants</td><td>Fieldworkers</td></tr><tr><td>Continuous feedback to and from community</td><td>Fieldworkers and other key gatekeepers</td></tr><tr><td>Feedback of results</td><td>Involves all of the above, for example, preliminary study results disseminated</td></tr></table> |
dcde08882608078e1422ef350ea31e1db063d7aaddc9c5361fcb8e14679df2fd.png | complex | <table><tr><td rowspan="2">Item</td><td rowspan="2">N</td><td colspan="2">Change +</td><td colspan="2">No change</td><td colspan="2">Change -</td><td rowspan="2">p</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Habit: days’ sunbathing on the beach</td><td>228</td><td>73</td><td>32.0</td><td>112</td><td>49.1</td><td>43</td><td>18.9</td><td>0.108</td></tr><tr><td>Habit: hours per day</td><td>224</td><td>75</td><td>33.5</td><td>101</td><td>45.1</td><td>48</td><td>21.4</td><td>0.068</td></tr><tr><td>Habit: mid-day sun exposure</td><td>222</td><td>73</td><td>32.9</td><td>100</td><td>45.0</td><td>49</td><td>22.1</td><td>0.049</td></tr><tr><td>Sunburn experienced during the previous summer</td><td>227</td><td>60</td><td>26.4</td><td>131</td><td>57.7</td><td>36</td><td>15.9</td><td>0.051</td></tr><tr><td>Practice: sunshade</td><td>225</td><td>44</td><td>19.6</td><td>99</td><td>44.0</td><td>82</td><td>36.4</td><td>0.006</td></tr><tr><td>Practice: sunglasses</td><td>227</td><td>62</td><td>27.3</td><td>101</td><td>44.5</td><td>64</td><td>28.2</td><td>0.167</td></tr><tr><td>Practice: sunhat</td><td>215</td><td>45</td><td>20.9</td><td>118</td><td>54.9</td><td>52</td><td>24.2</td><td>0.529</td></tr><tr><td>Practice: long-sleeves, long trousers</td><td>221</td><td>11</td><td>5.0</td><td>193</td><td>87.3</td><td>17</td><td>7.7</td><td>0.690</td></tr><tr><td>Practice: avoid mid-day exposure</td><td>225</td><td>78</td><td>34.7</td><td>97</td><td>43.1</td><td>50</td><td>22.2</td><td>0.052</td></tr><tr><td>Practice: use suncream</td><td>227</td><td>69</td><td>30.4</td><td>102</td><td>44.9</td><td>56</td><td>24.7</td><td>0.547</td></tr></table> |
2319f37a13507dc5ec61d0e93e7b1b510330697251e7168aa57be8339950778b.png | simple | <table><tr><td>Overlap size</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td><td>16</td><td>17</td></tr><tr><td>Frequency</td><td>151</td><td>22</td><td>9</td><td>13</td><td>4</td><td>1</td><td>10</td><td>1</td><td>0</td><td>1</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td></tr></table> |
75d16f8e43d8fc87e579a0cf3a074fbf85516d89f43aa46fdf15242fe326d0b2.png | simple | <table><tr><td>Sample</td><td>R<sub>apprent</sub> (U/mg)</td><td>K<sub>M</sub> (mM)</td><td>k<sub>cat</sub> (min<sup>−1</sup>)</td></tr><tr><td>GOD + HRP</td><td>165</td><td>112 ± 8.9</td><td>5.0 ± 0.2</td></tr><tr><td>GNC-HNC-HMS</td><td>162</td><td>119 ± 8.1</td><td>4.8 ± 0.3</td></tr><tr><td>GOD-HRP-HMS</td><td>136</td><td>136 ± 9.8</td><td>3.3 ± 0.1</td></tr><tr><td>GOD + HNC-HMS</td><td>145</td><td>127 ± 8.5</td><td>3.8 ± 0.2</td></tr><tr><td>HRP + GNC-HMS</td><td>149</td><td>131 ± 9.1</td><td>3.6 ± 0.1</td></tr><tr><td>GNC-HNC-HMS[b]</td><td>151</td><td>132 ± 9.3</td><td>3.7 ± 0.2</td></tr></table> |
209999d7577620c503f9a22f436bf50fade0f7334512ba6b736e0151b9d6597e.png | complex | <table><tr><td rowspan="2">Academic year</td><td rowspan="2">Number of students</td><td colspan="3">Verbally noted by student during simulation* N(%)</td><td colspan="3">Written in note after simulation N(%)</td></tr><tr><td>Student discovered that acetaminophen was administered n(%)</td><td>Student established the dosage of acetaminophen</td><td>Student stated that the dose was too high</td><td>Student identified medication error in write up</td><td>Male</td><td>Female</td></tr><tr><td>2010-11</td><td>114</td><td>88 (77)</td><td>44 (39)</td><td>12 (11)</td><td>12 (11)</td><td>4 (4)</td><td>8 (7)</td></tr><tr><td>2011-12</td><td>108</td><td>44 (41)</td><td>49 (45)</td><td>9 (8)</td><td>9 (8)</td><td>8 (7)</td><td>1 (1)</td></tr><tr><td>2012-13</td><td>118</td><td>102 (86)</td><td>68 (58)</td><td>16 (14)</td><td>13 (11)</td><td>7 (6)</td><td>6 (5)</td></tr><tr><td>Total</td><td>340</td><td>234 (69)</td><td>161 (47)</td><td>37 (11)</td><td>34 (10)</td><td>19 (6)</td><td>15 (4)</td></tr></table> |
f4b343291f9a29355a1c96cc96c02643753e869f01d286141e6b2c362230c6da.png | simple | <table><tr><td></td><td>Loci</td><td>Ref</td><td>Var</td><td>Gene</td><td>Variant type</td><td>Novel</td><td>Frequency of Mutation</td></tr><tr><td><i>Mismatch Repair</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><i>80149981</i></td><td><i>A</i></td><td><i>G</i></td><td><i>MSH3</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.60</i></td></tr><tr><td></td><td><i>80168937</i></td><td><i>G</i></td><td><i>A</i></td><td><i>MSH3</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.51</i></td></tr><tr><td></td><td><i>79950724</i></td><td><i>G</i></td><td><i>C</i></td><td><i>MSH3</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.02</i></td></tr><tr><td></td><td><i>48023115</i></td><td><i>T</i></td><td><i>C</i></td><td><i>MSH6</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.14</i></td></tr><tr><td></td><td><i>48030588</i></td><td><i>C</i></td><td><i>T</i></td><td><i>MSH6</i></td><td><i>stopgain</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td><i>Tumor Suppressor</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><i>63410110</i></td><td><i>T</i></td><td><i>C</i></td><td><i>AMER1</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.08</i></td></tr><tr><td></td><td><i>63412690</i></td><td><i>A</i></td><td><i>C</i></td><td><i>AMER1</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>63411276</i></td><td><i>G</i></td><td><i>A</i></td><td><i>AMER1</i></td><td><i>stopgain</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>63411684</i></td><td><i>G</i></td><td><i>T</i></td><td><i>AMER1</i></td><td><i>nonsynonymous SNV</i></td><td><i>1</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>112162854</i></td><td><i>T</i></td><td><i>C</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.52</i></td></tr><tr><td></td><td><i>112164561</i></td><td><i>G</i></td><td><i>A</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.49</i></td></tr><tr><td></td><td><i>112176325</i></td><td><i>G</i></td><td><i>A</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.49</i></td></tr><tr><td></td><td><i>112176559</i></td><td><i>T</i></td><td><i>G</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.54</i></td></tr><tr><td></td><td><i>112177171</i></td><td><i>G</i></td><td><i>A</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.59</i></td></tr><tr><td></td><td><i>112176756</i></td><td><i>T</i></td><td><i>A</i></td><td><i>APC</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.57</i></td></tr><tr><td></td><td><i>112175770</i></td><td><i>G</i></td><td><i>A</i></td><td><i>APC</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.49</i></td></tr><tr><td></td><td><i>112164586</i></td><td><i>C</i></td><td><i>T</i></td><td><i>APC</i></td><td><i>stopgain</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>7579472</i></td><td><i>G</i></td><td><i>C</i></td><td><i>TP53</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.40</i></td></tr><tr><td></td><td><i>48604664</i></td><td><i>C</i></td><td><i>T</i></td><td><i>SMAD4</i></td><td><i>nonsynonymous SNV</i></td><td><i>1</i></td><td><i>0.08</i></td></tr><tr><td><i>Oncogenes</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><i>70118935</i></td><td><i>C</i></td><td><i>T</i></td><td><i>SOX9</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.13</i></td></tr><tr><td></td><td><i>114912121</i></td><td><i>G</i></td><td><i>A</i></td><td><i>TCF7L2</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.08</i></td></tr><tr><td></td><td><i>114910829</i></td><td><i>A</i></td><td><i>G</i></td><td><i>TCF7L2</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.05</i></td></tr><tr><td></td><td><i>30732970</i></td><td><i>G</i></td><td><i>A</i></td><td><i>TGFBR2</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>30713842</i></td><td><i>C</i></td><td><i>T</i></td><td><i>TGFBR2</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.02</i></td></tr><tr><td></td><td><i>178916890</i></td><td><i>C</i></td><td><i>T</i></td><td><i>PIK3CA</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>178952085</i></td><td><i>A</i></td><td><i>G</i></td><td><i>PIK3CA</i></td><td><i>nonsynonymous SNV</i></td><td><i>0</i></td><td><i>0.06</i></td></tr><tr><td></td><td><i>25368462</i></td><td><i>C</i></td><td><i>T</i></td><td><i>KRAS</i></td><td><i>synonymous SNV</i></td><td><i>0</i></td><td><i>0.67</i></td></tr></table> |
bf4d498b720a3f6576915a338ccd5386ba9eca99d08ce640e66d600cfb536ce9.png | complex | <table><tr><td> </td><td> </td><td colspan="3"><i>P. falciparum </i>ortholog</td><td colspan="2"><i>P. vivax </i>ortholog</td></tr><tr><td>Protein description</td><td>Ortholog group</td><td>PlasmoDB Gene ID</td><td>SP prediction</td><td>Predicted localization</td><td>PlasmoDB Gene ID</td><td>SP prediction*</td></tr><tr><td>Proline tRNA synthetase</td><td>OG4_11662</td><td>PFI1240c</td><td>+</td><td>Apicoplast</td><td>PVX_099680 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10599</td><td>PFL0670c</td><td>-</td><td>Cytosol</td><td>PVX_123380</td><td>-</td></tr><tr><td>Asparagine tRNA synthetase</td><td>OG4_44547</td><td>PFE0475w</td><td>+</td><td>Apicoplast</td><td>PVX_098040 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10251</td><td>PFB0525w</td><td>-</td><td>Cytosol</td><td>PVX_002940</td><td>-</td></tr><tr><td>Methionine tRNA synthetase</td><td>OG4_47490</td><td>PF10_0053</td><td>+</td><td>Apicoplast</td><td>PVX_094445 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10161</td><td>PF10_0340</td><td>-</td><td>Cytosol</td><td>PVX_110980</td><td>-</td></tr><tr><td>Leucine tRNA synthetase</td><td>OG4_11105</td><td>PF08_0011</td><td>+</td><td>Apicoplast</td><td>PVX_088945 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10828</td><td>PFF1095w</td><td>-</td><td>Cytosol</td><td>PVX_114255</td><td>-</td></tr><tr><td>Glutamate tRNA amidotransferase subunit A</td><td>OG4_10803</td><td>PFD0780w</td><td>+</td><td>Apicoplast</td><td>PVX_089895 ®</td><td>+</td></tr><tr><td>Initiation Factor-1</td><td>OG4_12019</td><td>MAL8P1.27</td><td>+</td><td>Apicoplast</td><td>PVX_089095 ®</td><td>+</td></tr><tr><td>Initiation Factor-3</td><td>OG4_14117</td><td>PF14_0658</td><td>+</td><td>Apicoplast</td><td>PVX_117015 ®</td><td>+</td></tr><tr><td>DNA gyrase subunit A</td><td>OG4_12828</td><td>PFL1120c</td><td>+</td><td>Apicoplast</td><td>PVX_123795 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10491</td><td>PF14_0316</td><td>-</td><td>Nucleus</td><td>PVX_084855</td><td>-</td></tr><tr><td>DNA gyrase subunit B</td><td>OG4_12159</td><td>PFL1915w</td><td>+</td><td>Apicoplast</td><td>PVX_100925 ®</td><td>+</td></tr><tr><td> </td><td>OG4_10746</td><td>PF10_0412</td><td>-</td><td>Nucleus</td><td>PVX_111340</td><td>-</td></tr><tr><td>Ferredoxin</td><td>OG4_14702</td><td>MAL13P1.95</td><td>+</td><td>Apicoplast</td><td>PVX_122725 ®</td><td>+</td></tr></table> |
701b70d6388acbafa85909b48b9f0b7e15f42a1f3f5957cf3a2b1d69358c49a9.png | simple | <table><tr><td>Mass Range (Daltons)</td><td>WPH-P % Protein</td><td>WPH-AT % Protein</td></tr><tr><td>>20,000</td><td>44</td><td>13</td></tr><tr><td>5000–20,000</td><td>17</td><td>20</td></tr><tr><td>1500–5000</td><td>16</td><td>23</td></tr><tr><td>1000–1500</td><td>6</td><td>8</td></tr><tr><td>500–1000</td><td>8</td><td>12</td></tr><tr><td><500</td><td>9</td><td>23</td></tr></table> |
96c29a546d34ae2231a8559c0700c1f7289a564ac48b51794d79d1364b22a2ff.png | simple | <table><tr><td>Number of patients</td><td>Total</td></tr><tr><td> </td><td>n = 2,270</td></tr><tr><td>Age, years (SD)</td><td>61.7 (17.0)</td></tr><tr><td>Sex, male (%)</td><td>1,277 (56.3)</td></tr><tr><td>Height, metres (SD)</td><td>1.68 (0.11)</td></tr><tr><td>Weight, kg (SD)</td><td>78.1 (26.0)</td></tr><tr><td>BMI, mean (SD)</td><td>27.6 (8.3)</td></tr><tr><td>BMI, n (%)</td><td> </td></tr><tr><td><24</td><td>1,039 (45.9)</td></tr><tr><td>25-29</td><td>594 (26.2)</td></tr><tr><td>30-40</td><td>463 (20.4)</td></tr><tr><td>>40</td><td>169 (7.5)</td></tr><tr><td>Admission type</td><td> </td></tr><tr><td>Medical, n (%)</td><td>2,270 (100)</td></tr><tr><td>Surgical</td><td>0</td></tr><tr><td>ICU admission diagnosis, n (%)</td><td> </td></tr><tr><td>Aspiration pneumonia</td><td>330 (14.5)</td></tr><tr><td>Bacterial/viral pneumonia</td><td>911 (40.1)</td></tr><tr><td>Sepsis (other than urinary tract)</td><td>859 (37.8)</td></tr><tr><td>Sepsis of urinary tract origin</td><td>170 (7.5)</td></tr><tr><td>APACHE II score, mean (SD)</td><td>23.9 (7.9)</td></tr><tr><td>Days from hospital admission to ICU admission (hours), median [IQR]</td><td>6.55 [0.08, 65.08]</td></tr><tr><td>Days from hospital admission to ICU admission, n (%)</td><td> </td></tr><tr><td>[0–1] day</td><td>1,437 (63.4)</td></tr><tr><td>[1-3] days</td><td>303 (13.4)</td></tr><tr><td>>3 days</td><td>527 (23.3)</td></tr><tr><td>Length of ICU stay (days), median [IQR]</td><td>11.5 [6.9-21.4]</td></tr><tr><td>Length of hospital stay (days), median [IQR]</td><td>23.8 [13.8-48.5]</td></tr><tr><td>Length of mechanical ventilation (days), median [IQR]</td><td>8.4 [4.6-19.2]</td></tr><tr><td>Ventilator-free days, median [IQR]</td><td>46.4 [4.0-55.0]</td></tr><tr><td>Mortality (60 day),%</td><td>30.5</td></tr></table> |
20c69efd582f1c84969009440cf41fc1b59144e74502d185c206f7c8246be5ca.png | complex | <table><tr><td></td><td colspan="3">HIV Uninfected</td><td colspan="3">HIV Infected</td></tr><tr><td>Race/ethnicity, Region</td><td>N (%)</td><td>Crude OR (95% CI)*</td><td>Adj. OR (95% CI)*</td><td>N (%)</td><td>Crude OR (95% CI)*</td><td>Adj. OR (95% CI)*</td></tr><tr><td>United States White</td><td>696 (17.7)</td><td>Referent</td><td>Referent</td><td>43 (1.1)</td><td>2.36 (1.17, 4.76)</td><td>1.04 (0.38, 2.79)</td></tr><tr><td>United States Black</td><td>1,638 (41.7)</td><td>1.67 (1.31, 2.13)</td><td>1.84 (1.42, 2.39)</td><td>419 (10.7)</td><td>1.89 (1.38, 2.58)</td><td>2.60 (1.83, 3.71)</td></tr><tr><td>United States Hispanic</td><td>65 (1.7)</td><td>1.24 (0.63, 2.46)</td><td>1.18 (0.56, 2.48)</td><td>7 (0.2)</td><td>4.58 (1.01, 20.76)</td><td>3.30 (0.54, 20.19)</td></tr><tr><td>United States Other</td><td>40 (1.0)</td><td>1.08 (0.44, 2.63)</td><td>1.13 (0.45, 2.83)</td><td>2 (0.1)</td><td>n/a</td><td>n/a</td></tr><tr><td>Africa</td><td>123 (3.1)</td><td>3.28 (2.14, 5.03)</td><td>2.28 (1.45, 3.59)</td><td>21 (0.5)</td><td>1.44 (0.47, 4.36)</td><td>0.97 (0.32, 3.00)</td></tr><tr><td>Americas</td><td>482 (12.3)</td><td>1.72 (1.27, 2.33)</td><td>1.36 (0.97, 1.91)</td><td>64 (1.6)</td><td>5.73 (3.36, 9.79)</td><td>5.12 (2.84, 9.23)</td></tr><tr><td>East Asia</td><td>79 (2.0)</td><td>2.36 (1.38, 4.03)</td><td>1.62 (0.93, 2.80)</td><td>0 (0.0)</td><td>n/a</td><td>n/a</td></tr><tr><td>Europe/Middle East</td><td>28 (0.7)</td><td>4.58 (2.10, 9.97)</td><td>3.38 (1.47, 7.76)</td><td>0 (0.0)</td><td>n/a</td><td>n/a</td></tr><tr><td>India</td><td>75 (1.9)</td><td>7.77 (4.69, 12.85)</td><td>5.09 (3.01, 8.60)</td><td>0 (0.0)</td><td>n/a</td><td>n/a</td></tr><tr><td>Southeast Asia</td><td>147 (3.7)</td><td>3.98 (2.68, 5.90)</td><td>2.88 (1.90, 4.37)</td><td>2 (0.1)</td><td>6.10 (0.38, 98.36)</td><td>n/a</td></tr></table> |
4dc992187a799475aa659f780f4e7693b1a6f70088faaab9c025ec04055e6c4b.png | complex | <table><tr><td></td><td colspan="4">Group A (<i>n</i> = 45)</td><td>Group B (<i>n</i> = 31)</td><td></td><td>Group C (<i>n</i> = 18)</td><td></td></tr><tr><td></td><td>Stool</td><td></td><td>Duodenal fluid</td><td></td><td colspan="4">Stool</td></tr><tr><td></td><td colspan="2">Kato-Katz</td><td colspan="2">Filtration</td><td colspan="2">Kato-Katz</td><td colspan="2">Kato-Katz</td></tr><tr><td>Helminth species</td><td>Positive/examined (%)</td><td>Intensity (epg)</td><td>Positive/examined (%)</td><td>Intensity<sup>b</sup></td><td>Positive/examined (%)</td><td>Intensity (epg)</td><td>Positive/examined (%)</td><td>Intensity (epg)</td></tr><tr><td></td><td></td><td>Median (range)</td><td></td><td>Median (range)</td><td></td><td>Median (range)</td><td></td><td>Median (range)</td></tr><tr><td><i>Opisthorchis viverrini</i></td><td>45/45 (100)</td><td>900 (60–13,710)</td><td>19/32 (59.4)</td><td>24 (1–7140)</td><td>15/29 (52.7)</td><td>40 (24–56)</td><td>9/18 (50.0)</td><td>24 (24–40)</td></tr><tr><td>Hookworm<sup>a</sup></td><td>18/45 (40.0)</td><td>180 (30–2940)</td><td>4/32 (12.5)</td><td>13 (5–27)</td><td>6/29 (20.7)</td><td>24 (24–72)</td><td>0/18 (0)</td><td>n.a.</td></tr><tr><td><i>T. trichiura</i></td><td>4/45 (8.9)</td><td>n.d.</td><td>0/32 (0)</td><td>n.a.</td><td>0/29 (0)</td><td>n.d.</td><td>0/18 (0)</td><td>n.a.</td></tr><tr><td><i>Taenia</i> spp<i>.</i><sup>a</sup></td><td>7/45 (15.6)</td><td>n.d.</td><td>0/32 (0)</td><td>n.a.</td><td>0/29/0)</td><td>n.a.</td><td>0/18 (0)</td><td>n.a.</td></tr><tr><td><i>Trichostrongylus</i> spp<i>.</i><sup>b</sup></td><td>0/45 (0)</td><td>n.a.</td><td>0/32 (0)</td><td>n.a.</td><td>3/29 (10.3)</td><td>n.d.</td><td>2/18 (11.1)</td><td>n.d.</td></tr></table> |
9c7bacfa7c83c491de7c453a953625d7553f75897416cbf0e69a32f80951d832.png | simple | <table><tr><td>OPEN APPENDECTOMY</td><td>Nr. UNITS</td><td>TOTAL</td></tr><tr><td>2/0 silk suture</td><td>3</td><td>0.4 €</td></tr><tr><td>2/0 braided absorbable suture</td><td>2</td><td>4.3 €</td></tr><tr><td>Suction device</td><td>1</td><td>2.3 €</td></tr><tr><td>TOTAL</td><td> </td><td>7 €</td></tr><tr><td>LAPAROSCOPIC APPENDECTOMY</td><td> </td><td> </td></tr><tr><td>Hasson Trocar</td><td>1</td><td>37 €</td></tr><tr><td>5 mm Trocar</td><td>2</td><td>70 €</td></tr><tr><td>Endoclinch</td><td>1</td><td>75 €</td></tr><tr><td>Lap. Irrigation/suction device</td><td>1s</td><td>70 €</td></tr><tr><td>Biosyn® 3/0</td><td>2</td><td>4.3 €</td></tr><tr><td>1-Ti-Cron® suture</td><td>1</td><td>3 €</td></tr><tr><td>TOTAL</td><td> </td><td>259.3 €</td></tr><tr><td>DIFFERENTIAL</td><td> </td><td>+ 252.3 €</td></tr></table> |
a7a62e6021e0eb4ee22444a8c1c6c426d116d63d0edd56ef4c0913e4490517f3.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">HIV Knowledge Score</td><td rowspan="2">Chi square</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>High Score</td><td>Medium Score</td><td>Low Score</td></tr><tr><td colspan="6">Age</td></tr><tr><td> 15–19 years</td><td>5.2 %</td><td>1.9 %</td><td>4.4 %</td><td rowspan="7">17.549</td><td rowspan="7">0.130</td></tr><tr><td> 20–24 years</td><td>10.1 %</td><td>3.7 %</td><td>8.1 %</td></tr><tr><td> 25–29 years</td><td>9.7 %</td><td>3.6 %</td><td>7.3 %</td></tr><tr><td> 30–34 years</td><td>7.6 %</td><td>2.7 %</td><td>5.0 %</td></tr><tr><td> 35–39 years</td><td>6.0 %</td><td>2.0 %</td><td>4.2 %</td></tr><tr><td> 40–44 years</td><td>4.9 %</td><td>1.8 %</td><td>3.6 %</td></tr><tr><td> 45–49 years</td><td>3.7 %</td><td>1.4 %</td><td>2.9 %</td></tr><tr><td colspan="6">Wealth Index</td></tr><tr><td> Poorest</td><td>4.5 %</td><td>2.0 %</td><td>4.1 %</td><td rowspan="5">72.757</td><td rowspan="5"><0.0001<sup>*</sup></td></tr><tr><td> Poor</td><td>6.1 %</td><td>2.3 %</td><td>6.0 %</td></tr><tr><td> Middle</td><td>8.9 %</td><td>3.5 %</td><td>6.8 %</td></tr><tr><td> Rich</td><td>11.8 %</td><td>4.0 %</td><td>8.7 %</td></tr><tr><td> Richest</td><td>15.9 %</td><td>5.3 %</td><td>10.0 %</td></tr><tr><td colspan="6">Highest Education</td></tr><tr><td> No Education</td><td>5.7 %</td><td>2.8 %</td><td>6.5 %</td><td rowspan="4">159.963</td><td rowspan="4"><0.0001<sup>*</sup></td></tr><tr><td> Primary</td><td>12.1 %</td><td>4.8 %</td><td>10.4 %</td></tr><tr><td> Secondary</td><td>22.7 %</td><td>7.8 %</td><td>15.5 %</td></tr><tr><td> Higher</td><td>6.8 %</td><td>1.6 %</td><td>3.3 %</td></tr><tr><td colspan="6">Region</td></tr><tr><td> Barisal</td><td>6.8 %</td><td>1.8 %</td><td>3.5 %</td><td rowspan="7">85.210</td><td rowspan="7"><0.0001<sup>*</sup></td></tr><tr><td> Chittagong</td><td>7.2 %</td><td>2.7 %</td><td>6.2 %</td></tr><tr><td> Dhaka</td><td>8.4 %</td><td>3.5 %</td><td>6.8 %</td></tr><tr><td> Khulna</td><td>8.0 %</td><td>3.1 %</td><td>6.1 %</td></tr><tr><td> Rajshahi</td><td>6.3 %</td><td>2.5 %</td><td>5.0 %</td></tr><tr><td> Rangpur</td><td>5.9 %</td><td>1.7 %</td><td>4.0 %</td></tr><tr><td> Sylhet</td><td>4.6 %</td><td>1.7 %</td><td>4.1 %</td></tr><tr><td colspan="6">Type of Residence</td></tr><tr><td> Urban</td><td>20.3 %</td><td>6.9 %</td><td>14.1 %</td><td rowspan="2">13.359</td><td rowspan="2">0.001<sup>*</sup></td></tr><tr><td> Rural</td><td>26.9 %</td><td>10.2 %</td><td>21.5 %</td></tr><tr><td colspan="6">Sex of Household Head</td></tr><tr><td> Male</td><td>41.9 %</td><td>15.6 %</td><td>32.1 %</td><td rowspan="2">12.201</td><td rowspan="2">0.002<sup>*</sup></td></tr><tr><td> Female</td><td>5.4 %</td><td>1.5 %</td><td>3.6 %</td></tr></table> |
5d23f8ec26b49a37e070bdbd6f544327a67af24fa0f3587d98c75c5d58bdbef3.png | simple | <table><tr><td>Social variable</td><td>Nonpregnant women</td><td>Pregnant women </td></tr><tr><td>Age (years)</td><td>29.250 ± 2.314</td><td>28.333 ± 1.971</td></tr><tr><td>Ethnicity</td><td>Han</td><td>Han</td></tr><tr><td>Occupation</td><td> </td><td> </td></tr><tr><td> Housewife</td><td>0</td><td>3</td></tr><tr><td> Employee</td><td>20</td><td>27</td></tr><tr><td>Level of education</td><td> </td><td> </td></tr><tr><td> <Technical</td><td>6</td><td>10</td></tr><tr><td> Bachelor</td><td>9</td><td>13</td></tr><tr><td> Master</td><td>5</td><td>7</td></tr><tr><td>Economic status</td><td>Regular</td><td>Regular</td></tr></table> |
69a14297f3b6ffb9f6ac5765afb63c874d1ad395637b0e9af55a3cabb8999f1d.png | simple | <table><tr><td>Diet ingredients, % (DM basis)</td><td>Ratio</td></tr><tr><td>Corn stalk pellets</td><td>60.0</td></tr><tr><td>Corn</td><td>24.8</td></tr><tr><td>Soybean meal</td><td>10.4</td></tr><tr><td>Wheat bran</td><td>3.2</td></tr><tr><td>Sodium chloride</td><td>0.4</td></tr><tr><td>Calcium hydrophosphate</td><td>0.8</td></tr><tr><td>Premix<sup>a</sup></td><td>0.4</td></tr><tr><td>Nutrient composition (DM basis)</td><td> </td></tr><tr><td>Dry matter, %</td><td>93.56</td></tr><tr><td>Digestible energy, MJ/kg</td><td>8.13</td></tr><tr><td>Crude protein, %</td><td>10.39</td></tr><tr><td>Ether extract, %</td><td>8.15</td></tr><tr><td>Neutral detergent fiber, %</td><td>22.79</td></tr><tr><td>Acid detergent fiber, %</td><td>16.0</td></tr><tr><td>Vitamin E, IU/kg</td><td>5.08</td></tr></table> |
f4fa532e3f2d13dc85440af2436718b165901e0ec7ca9345e52364d8fafea8e1.png | simple | <table><tr><td>Comp-ound</td><td>Docking Score</td><td>Residue involv-ed in hydrogen bonds</td><td>Residues involv-ed in π-π intera-ctions </td></tr><tr><td>9</td><td>-6.76</td><td>Asp-168</td><td>Lys 53, Arg 67</td></tr><tr><td>10</td><td>-6.70</td><td>Asp-168</td><td>Arg 67</td></tr><tr><td>11</td><td>-4.30</td><td>Asp-168</td><td>His 148, Arg 67</td></tr><tr><td>12</td><td>-5.29</td><td>Asp-168</td><td>-</td></tr><tr><td>13</td><td>-4.52</td><td>Asp-168</td><td>His 174, Arg 67</td></tr><tr><td>14</td><td>-4.69</td><td>Met-109</td><td>Phe 169</td></tr><tr><td>15</td><td>-5.19</td><td>Asp-168</td><td>Arg 67</td></tr></table> |
4c9b46fa8f3665955350d523641665aed554e77706e3607e895cbd119bca41d7.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Positive influenza A</td><td rowspan="2">Positive influenza B</td><td rowspan="2">Negative samples</td></tr><tr><td>Seasonal H1N1</td><td>2009 pandemic H1N1</td><td>H3N2</td><td>H5N1</td></tr><tr><td>RT-qPCR</td><td>14</td><td>39</td><td>29</td><td>2</td><td>69</td><td>80</td></tr><tr><td>Multiplex DPO PCR</td><td>13</td><td>25</td><td>16</td><td>2</td><td>43</td><td>134</td></tr><tr><td>Positive Concordant Percentage</td><td colspan="4">56 (66.67%, 56/84)</td><td>43(62.32%, 43/69)</td><td>____</td></tr></table> |
c46c6d2598124f157f21b7d381a94da5441de45efa415bfe7dad2b94d9fcf93e.png | simple | <table><tr><td>Animal name</td><td>Genotype</td><td>Sex</td><td>Age (m)</td><td>Brain weight (g)</td><td>CA1 thickness (μm)</td><td>Cortex thickness (μm)</td><td>N<sub>f</sub></td><td>N<sub>n</sub></td></tr><tr><td>AN1</td><td>WT</td><td>M</td><td>8–9</td><td>NA</td><td>56</td><td>800</td><td>7</td><td>3</td></tr><tr><td>AN4</td><td>WT</td><td>M</td><td>8–9</td><td>0.350</td><td>51</td><td>790</td><td>16</td><td>0</td></tr><tr><td>AN18</td><td>WT</td><td>M</td><td>7–8</td><td>0.334</td><td>55</td><td>760</td><td>8</td><td>10</td></tr><tr><td>AN19</td><td>WT</td><td>F</td><td>7–8</td><td>0.324</td><td>51</td><td>690</td><td>41</td><td>30</td></tr><tr><td>AN20</td><td>WT</td><td>F</td><td>7–8</td><td>0.392</td><td>51</td><td>690</td><td>16</td><td>37</td></tr><tr><td>AN21</td><td>WT</td><td>F</td><td>8–9</td><td>0.328</td><td>51</td><td>690</td><td>31</td><td>34</td></tr><tr><td>AN10</td><td>+/−</td><td>M</td><td>8–9</td><td>0.364</td><td>NA</td><td>NA</td><td>42</td><td>33</td></tr><tr><td>AN11</td><td>+/−</td><td>M</td><td>7–8</td><td>0.356</td><td>53</td><td>760</td><td>10</td><td>15</td></tr><tr><td>AN12</td><td>−/+</td><td>F</td><td>7–8</td><td>0.310</td><td>50</td><td>800</td><td>12</td><td>18</td></tr><tr><td>AN16</td><td>−/+</td><td>M</td><td>8–9</td><td>0.332</td><td>60</td><td>800</td><td>15</td><td>18</td></tr><tr><td>AN5</td><td>Tau</td><td>F</td><td>8–9</td><td>0.192</td><td>26</td><td>580</td><td>17</td><td>15</td></tr><tr><td>AN13</td><td>Tau</td><td>F</td><td>8–9</td><td>0.226</td><td>22</td><td>580</td><td>14</td><td>10</td></tr><tr><td>AN14</td><td>Tau</td><td>F</td><td>8–9</td><td>0.236</td><td>27</td><td>580</td><td>24</td><td>25</td></tr><tr><td>AN15</td><td>Tau</td><td>M</td><td>8–9</td><td>0.214</td><td>26</td><td>580</td><td>10</td><td>18</td></tr><tr><td>AN22</td><td>Tau</td><td>M</td><td>7–8</td><td>NA</td><td>28</td><td>550</td><td>20</td><td>10</td></tr><tr><td>AN23</td><td>Tau</td><td>M</td><td>7–8</td><td>0.198</td><td>24</td><td>550</td><td>7</td><td>10</td></tr><tr><td>AN24</td><td>Tau</td><td>F</td><td>7–8</td><td>0.232</td><td>27</td><td>550</td><td>14</td><td>14</td></tr><tr><td>AN25</td><td>Tau</td><td>M</td><td>7–8</td><td>0.226</td><td>26</td><td>NA</td><td>29</td><td>27</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>Total</td><td>333</td><td>327</td></tr></table> |
5ea32a04660bc95dc31e8f659f75a61225b5c1b3b5f26c2685c64000e4de7101.png | complex | <table><tr><td>Wealth variable</td><td>Response options</td><td>Crude score</td><td>Rescaled crude score</td><td>Assigned weight</td><td>Weighted score</td></tr><tr><td rowspan="4">Main roof material</td><td>Cement/concrete</td><td>4</td><td>1.00</td><td>5</td><td>5.00</td></tr><tr><td>Corrugated iron</td><td>3</td><td>0.67</td><td> </td><td>3.35</td></tr><tr><td>Wood planks/wood</td><td>2</td><td>0.33</td><td> </td><td>1.65</td></tr><tr><td>Thatch / leaf/reed/bamboo</td><td>1</td><td>0.00</td><td> </td><td>0.00</td></tr><tr><td rowspan="6">Type of toilet facility</td><td>Flush to septic tank/sewer system/pit latrine</td><td>6</td><td>1.00</td><td>4</td><td>4.00</td></tr><tr><td>Ventilated improved pit latrine (VIP)</td><td>5</td><td>0.80</td><td> </td><td>3.20</td></tr><tr><td>Pit latrine with slab</td><td>4</td><td>0.60</td><td> </td><td>2.40</td></tr><tr><td>Pit latrine without slab / open pit</td><td>3</td><td>0.40</td><td> </td><td>1.60</td></tr><tr><td>Composting toilet</td><td>2</td><td>0.20</td><td> </td><td>0.80</td></tr><tr><td>No facility / bush / field</td><td>1</td><td>0.00</td><td> </td><td>0.00</td></tr><tr><td rowspan="6">Educational attainment</td><td>Higher</td><td>6</td><td>1.00</td><td>3</td><td>3.00</td></tr><tr><td>Complete secondary</td><td>5</td><td>0.80</td><td> </td><td>2.40</td></tr><tr><td>Incomplete secondary</td><td>4</td><td>0.60</td><td> </td><td>1.80</td></tr><tr><td>Complete primary</td><td>3</td><td>0.40</td><td> </td><td>1.20</td></tr><tr><td>Incomplete primary</td><td>2</td><td>0.20</td><td> </td><td>0.60</td></tr><tr><td>No education</td><td>1</td><td>0.00</td><td> </td><td>0.00</td></tr><tr><td rowspan="2">Household owns table</td><td>Yes</td><td>2</td><td>1.00</td><td>2</td><td>2.00</td></tr><tr><td>No</td><td>1</td><td>0.00</td><td> </td><td>0.00</td></tr><tr><td rowspan="2">Household has radio</td><td>Yes</td><td>2</td><td>1.00</td><td>1</td><td>1.00</td></tr><tr><td>No</td><td>1</td><td>0.00</td><td> </td><td>0.00</td></tr></table> |
2c6ce96d7b8f0a924e5ddfa701944b8288e724b36e9a38f0640b71a4169d952e.png | simple | <table><tr><td>Number</td><td>Raw CW (g)</td><td>Water Added (mL)</td><td>Mixing Condition</td><td>Final Liquid Volume (mL)</td><td>Recovery (g sugars/kg raw CW)</td></tr><tr><td>1</td><td>250</td><td>250</td><td>Mixer</td><td>170</td><td>19.7</td></tr><tr><td>2</td><td>150</td><td>250</td><td>Mixer</td><td>250</td><td>29.7</td></tr><tr><td>3</td><td>250</td><td>250</td><td>Shaking at 120 rpm (15 min)</td><td>250</td><td>24.8</td></tr><tr><td>4</td><td>150</td><td>250</td><td>Shaking at 120 rpm (15 min)</td><td>250</td><td>30.3</td></tr></table> |
af7db15cdd143e4639b5b31443f794fad862389a004791130e26c6c5a1108be5.png | simple | <table><tr><td></td><td>Correct</td><td>Under-triage</td><td>Over-triage</td><td>Total</td></tr><tr><td>All missions</td><td>67.5 (8589)</td><td>9.2 (1166)</td><td>23.4 (2974)</td><td>100.0 (12729)</td></tr><tr><td>A priority</td><td>23.1 (142)</td><td>-</td><td>76.9 (474)<sup>a</sup></td><td>100.0 (616)</td></tr><tr><td>B priority</td><td>13.9 (445)</td><td>7.8 (248)<sup>b</sup></td><td>78.3 (2500)<sup>b</sup></td><td>100.0 (3193)</td></tr><tr><td>C priority</td><td>87.5 (4933)</td><td>12.5 (704)<sup>c</sup></td><td>-</td><td>100.0 (5637)</td></tr><tr><td>D priority</td><td>93.5 (3069</td><td>6.5 (214)<sup>d</sup></td><td>-</td><td>100.0 (3283)</td></tr><tr><td>Male</td><td>65.2 (4090)</td><td>10.0 (627)</td><td>24.8 (1558)</td><td>100.0 (6275)</td></tr><tr><td>Female</td><td>69.7 (4461)</td><td>8.4 (537)</td><td>21.9 (1399)</td><td>100.0 (6397)</td></tr><tr><td>16–64 years</td><td>66.0 (3615)</td><td>7.0 (383)</td><td>27.0 (1477)</td><td>100.0 (5475)</td></tr><tr><td>65–74 years</td><td>67.7 (1313)</td><td>11.2 (218)</td><td>21.1 (409)</td><td>100.0 (1940)</td></tr><tr><td>75–84 years</td><td>69.6 (2160)</td><td>10.3 (319)</td><td>20.1 (623)</td><td>100.0 (3102)</td></tr><tr><td>85+ years</td><td>67.9 (1501)</td><td>11.1 (246)</td><td>21.0 (465)</td><td>100.0 (2212)</td></tr><tr><td>00:00–08:00</td><td>67.7 (1933)</td><td>8.8 (250)</td><td>23.5 (671)</td><td>100.0 (2854)</td></tr><tr><td>08:00–16:00</td><td>67.4 (3567)</td><td>9.5 (501)</td><td>23.1 (1223)</td><td>100.0 (5291)</td></tr><tr><td>16:00–24:00</td><td>67.5 (3081)</td><td>9.1 (414)</td><td>23.5 (1072)</td><td>100.0 (4567)</td></tr></table> |
c61ddc7e1b73413ca24ece263486990092fc69598185745613ee61e9cc08efa3.png | simple | <table><tr><td>Operation</td><td>Duration (ms)</td></tr><tr><td>Conceptual preparation (from picture onset to selecting the target concept)</td><td>175</td></tr><tr><td>Lemma retrievalForm encoding:</td><td>75</td></tr><tr><td>Phonological code retrieval</td><td>80</td></tr><tr><td>Syllabification</td><td>125</td></tr><tr><td>Phonetic encoding (till initiation of articulation)</td><td>145</td></tr><tr><td>Total</td><td>600</td></tr></table> |
c3fd6c550465cc08500742db0bb3d4104d212d0d9e873920d48f10dece1f1757.png | simple | <table><tr><td>Excluded species</td><td>Reasons for exclusion</td></tr><tr><td><i>Baissopsyche pura</i></td><td>Forewing venation not complete, key characters missing</td></tr><tr><td><i>Mesopsyche ordinata</i></td><td>Forewing width/length ratio at 0.48 much higher than that of all others (with typical ratio between 0.30 and 0.35 and two outliers at 0.27 and 0.38)</td></tr><tr><td><i>Mesopsyche justa</i></td><td>Base of forewing missing for holotype; inconsistent venation among holotype and paratypes.</td></tr><tr><td><i>Mesopsyche gentica</i></td><td>Base of forewing missing</td></tr><tr><td><i>Mesopsyche tortiva</i></td><td>Incomplete forewing and base of hind wing missing</td></tr><tr><td><i>Mesopsyche incompleta</i></td><td>Incomplete fore- and hind wings</td></tr><tr><td><i>Mesopsyche javorskii</i></td><td>Hind wing only</td></tr><tr><td><i>Mesopsyche tongchuanensis</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Mesopanorpodes wianamattensis</i></td><td>Anal area of forewing missing</td></tr><tr><td><i>Permopsyche robustus</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Mesoses optata</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Mesoses magna</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Mesoses gayndah</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Ptychopteropsis mirabilis</i></td><td>Incomplete forewing only</td></tr><tr><td><i>Turanopsyche venosa</i></td><td>Incomplete hind wing only</td></tr><tr><td><i>Ferghanopsyche rotundata</i></td><td>Incomplete forewing only</td></tr></table> |
06a3ee9a60434fc7ce7e94bc94e2b58333ece77cadeaed0181c7f5437bd04297.png | simple | <table><tr><td> </td><td>Cryptography authentication</td><td>Biometrics recognition</td></tr><tr><td>Authentication method</td><td>Digital</td><td>Analog</td></tr><tr><td>Authentication rule</td><td>Without error tolerance</td><td>With error tolerance</td></tr><tr><td>Data processing</td><td>Data is disordered</td><td>Data is processed but not disordered</td></tr><tr><td>Adoption of cryptography technique</td><td>Data can be encrypted and signed</td><td>Data cannot be encrypted or signed</td></tr></table> |
e40f0a29ccbbd64c3827d179372aa65f33e709d40ffbb84050d13490edb9c630.png | simple | <table><tr><td>Case</td><td>Removal of catheter</td><td>Antifungal treatment</td><td>Outcome</td><td>References</td></tr><tr><td>1</td><td>Yes</td><td>AmB (cumulative dose, 0.3 g)</td><td>Switching to permanent hemodialysis</td><td>[18]</td></tr><tr><td>2</td><td>Yes</td><td>AmB (cumulative dose, 2 g)</td><td>Cured</td><td>[20]</td></tr><tr><td>3</td><td>Yes</td><td>AmB + 5-FC</td><td>Died</td><td>[20]</td></tr><tr><td>4</td><td>Yes</td><td>AmB (cumulative dose, 1.4 g) + 5-FC (cumulative dose, 55 g)</td><td>Switching to permanent hemodialysis</td><td>[19]</td></tr><tr><td>5</td><td>Yes</td><td>MCZ × 3 days + AmB (cumulative dose, 0.5 g)</td><td>Cured</td><td>[16]</td></tr><tr><td>6</td><td>Yes</td><td>KCZ 400 mg/day × 2 days + FCZ 400 mg/day × 5 days</td><td>Cured</td><td>[21]</td></tr><tr><td>7</td><td>Yes</td><td>AmB 0.5 mg/kg/day × 6 weeks +5-FC × 4 weeks</td><td>Switching to permanent hemodialysis</td><td>[22]</td></tr><tr><td>8</td><td>Yes</td><td>(FCZ 200 mg/day + CPF 50 mg/day) × 5 days + AmB liposomal 400 mg/day × 7 days</td><td>Switching to permanent hemodialysis</td><td>[14]</td></tr><tr><td>9</td><td>Yes</td><td>FCZ200 mg/day × 6 days + AmB 0.5 mg/kg/day × 4 weeks</td><td>Switching to permanent hemodialysis</td><td>[15]</td></tr><tr><td>10</td><td>Yes</td><td>VCZ 500 mg × 8 days</td><td>Cured</td><td>[13]</td></tr><tr><td>11</td><td>No</td><td>AmB (cumulative dose, 2.5 g) + 5-FC 50 mg/kg × 6 weeks</td><td>Cured</td><td>[23]</td></tr><tr><td>12</td><td>No</td><td>AmB (cumulative dose, 1.9 g)</td><td>Cured</td><td>[17]</td></tr><tr><td>13</td><td>Yes</td><td>AmB 0.5 mg/kg/day × 6 weeks</td><td>Died</td><td>[24]</td></tr><tr><td>14</td><td>ND</td><td>ND</td><td>Died</td><td>[27]</td></tr><tr><td>15</td><td>No</td><td>(AmB + 5-FC) × 9 days + FCZ × 24 weeks</td><td>Cured</td><td>[26]</td></tr><tr><td>16</td><td>No</td><td>VCZ 400 mg/d × 10 days + AmB 100 mg/day × 4 days + </td><td>Cured</td><td>[25]</td></tr><tr><td>17</td><td>No</td><td>(VCZ 0.4 g/day + 5-FC 4 g/day) × 2 weeks</td><td>Cured</td><td>This study</td></tr><tr><td>18</td><td>No</td><td>(AmB 30 mg/days + 5-FC 4.5 g/day) × 4 weeks</td><td>Cured</td><td>This study</td></tr></table> |
9d50a0f318c1aa721622cd4d1d730d61872021b4ee2aff9f912a4aec09fd56e8.png | simple | <table><tr><td>CESD-10 score category</td><td>n</td><td>Total tremor score</td><td>ETEA score</td><td>Number (%) who had been prescribed medication for tremor</td></tr><tr><td>0–9 (no or minimal depressive symptoms)</td><td>47</td><td>19.6 ± 6.2</td><td>19.9 ± 16.4</td><td>28 (59.6)</td></tr><tr><td>10–19 (moderate depressive symptoms)</td><td>37</td><td>22.1 ± 5.8</td><td>28.4 ± 16.4</td><td>24 (64.9)</td></tr><tr><td>≥20 (severe depressive symptoms)</td><td>7</td><td>19.0 ± 2.0</td><td>31.4 ± 17.6</td><td>7 (100)</td></tr><tr><td></td><td></td><td><i>p</i> = 0.36<sup>a</sup></td><td><i>p</i> = 0.01<sup>b</sup></td><td></td></tr></table> |
5942ecc1502a970835c1818d9cf51d041f7f27ac48f589d93bb26a30c8d57414.png | complex | <table><tr><td rowspan="2">Groups<sup>a</sup></td><td colspan="4">Immunization time</td></tr><tr><td>1<sup>st</sup></td><td>2<sup>nd</sup></td><td>3<sup>rd</sup></td><td>4<sup>th</sup></td></tr><tr><td>PBS</td><td>100 μl</td><td>100 μl</td><td>100 μl</td><td>100 μl</td></tr><tr><td>pEGFP<sup>b</sup></td><td>100 μg</td><td>100 μg</td><td>100 μg</td><td>100 μg</td></tr><tr><td>pGRA4<sup>c</sup></td><td>100 μg</td><td>100 μg</td><td>100 μg</td><td>100 μg</td></tr><tr><td>peptide<sup>d</sup></td><td>100 μg</td><td>100 μg</td><td>100 μg</td><td>100 μg</td></tr><tr><td>peptide/DNA</td><td>100 μg peptide</td><td>100 μg peptide</td><td>100 μg pGRA4</td><td>100 μg pGRA4</td></tr><tr><td>DNA/peptide</td><td>100 μg pGRA4</td><td>100 μg pGRA4</td><td>100 μg peptide</td><td>100 μg peptide</td></tr></table> |
a02b6ef623718fcf7a958a9b0165a52e700383a6324a5a795fb6f727374e2c54.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="2">Knowledge</td><td colspan="2">Value</td><td colspan="2">Opinion</td><td colspan="2">Practice</td></tr><tr><td>Mean ± SD</td><td><i>P</i> value</td><td>Mean ± SD</td><td><i>P</i> value</td><td>Mean ± SD</td><td><i>P</i> value</td><td>Mean ± SD</td><td><i>P</i> value</td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Male</td><td>41.6 ± 3.7</td><td rowspan="2">0.47</td><td>17.4 ± 2.2</td><td rowspan="2">0.88</td><td>18.3 ± 2.3</td><td rowspan="2">0.07</td><td>12.9 ± 2.2</td><td rowspan="2">0.76</td></tr><tr><td> Female</td><td>41.1 ± 3.6</td><td>18.3 ± 1.9</td><td>18.1 ± 1.9</td><td>12.9 ± 2.5</td></tr><tr><td>Age (in years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 25–34</td><td>40.9 ± 3.7</td><td rowspan="3">0.06</td><td>17.6 ± 2.1</td><td rowspan="3">0.96</td><td>18.1 ± 2.1</td><td rowspan="3">0.11</td><td>12.8 ± 2.5</td><td rowspan="3">0.42</td></tr><tr><td> 35–44</td><td>42.3 ± 3.5</td><td>17.7 ± 2.0</td><td>18.7 ± 2.0</td><td>13.3 ± 1.9</td></tr><tr><td> ≥45</td><td>42.4 ± 3.8</td><td>17.7 ± 2.3</td><td>19.1 ± 2.9</td><td>13.3 ± 2.0</td></tr><tr><td>Qualification</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> MDS</td><td>44.5 ± 2.9</td><td rowspan="2">0.00*</td><td>18.2 ± 1.9</td><td rowspan="2">0.07</td><td>20.2 ± 1.8</td><td rowspan="2">0.08</td><td>13.7 ± 0.4</td><td rowspan="2">0.01*</td></tr><tr><td> BDS</td><td>39.7 ± 2.9</td><td>17.7 ± 2.0</td><td>19.3 ± 1.6</td><td>12.5 ± 2.7</td></tr><tr><td>Work experience (in years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> <5</td><td>42.3 ± 4.2<sup>a</sup></td><td rowspan="3">0.04*</td><td>17.7 ± 2.0</td><td rowspan="3">0.82</td><td>18.9 ± 2.0</td><td rowspan="3">0.78</td><td>12.8 ± 2.5</td><td rowspan="3">0.37</td></tr><tr><td> 5–10</td><td>42.1 ± 3.3</td><td>17.8 ± 2.2</td><td>18.4 ± 1.9</td><td>12.9 ± 2.5</td></tr><tr><td> >10</td><td>40.7 ± 3.5<sup>a</sup></td><td>17.5 ± 2.1</td><td>17.8 ± 2.6</td><td>13.4 ± 1.7</td></tr><tr><td>Total</td><td>41.8 ± 3.7</td><td> </td><td>18.7 ± 2.8</td><td> </td><td>18.1 ± 1.4</td><td> </td><td>12.9 ± 2.3</td><td> </td></tr></table> |
6b0b977ba99a455639453361755287fda4fcf9cc4897f6816a9a8f319e7978de.png | simple | <table><tr><td>Variables</td><td> Frequency</td><td> Percent</td></tr><tr><td>Number of pregnancies</td><td> </td><td> </td></tr><tr><td> 1</td><td>161</td><td>29.7</td></tr><tr><td> 2-3</td><td>276</td><td>50.9</td></tr><tr><td> 4+</td><td>105</td><td>19.4</td></tr><tr><td>Gestational age</td><td> </td><td> </td></tr><tr><td> ≤16</td><td>10</td><td> 1.9</td></tr><tr><td> 17–24</td><td>134</td><td>24.7</td></tr><tr><td> 25–35</td><td>333</td><td>61.4</td></tr><tr><td> ≥36</td><td>65</td><td>12.0</td></tr><tr><td>Antenatal visit </td><td> </td><td> </td></tr><tr><td> Yes</td><td>312</td><td>57.6</td></tr><tr><td> No</td><td>230</td><td>42.4</td></tr><tr><td>Number of ANC visit (<i>n</i> = 312)</td><td> </td><td> </td></tr><tr><td> 1</td><td>122</td><td>39.1</td></tr><tr><td> 2-3</td><td>176</td><td>56.4</td></tr><tr><td> 4+</td><td>14</td><td> 4.5</td></tr><tr><td>Received information from health care providers</td><td> </td><td> </td></tr><tr><td> On HIV</td><td> </td><td> </td></tr><tr><td>Yes</td><td>346</td><td>63.8</td></tr><tr><td>No</td><td>196</td><td>36.2</td></tr><tr><td> On antenatal care</td><td> </td><td> </td></tr><tr><td>Yes</td><td>304</td><td>56.1</td></tr><tr><td>No</td><td>238</td><td>43.9</td></tr><tr><td> On MTCT</td><td> </td><td> </td></tr><tr><td>Yes</td><td>284</td><td>52.4</td></tr><tr><td>No</td><td>258</td><td>47.6</td></tr><tr><td> On infant feeding</td><td> </td><td> </td></tr><tr><td>Yes </td><td>181</td><td>33.4</td></tr><tr><td>No </td><td>361</td><td>66.6</td></tr><tr><td>Comprehensive knowledge of HIV/AIDS</td><td> </td><td> </td></tr><tr><td> Yes </td><td>346 </td><td>63.8 </td></tr><tr><td> No</td><td>196</td><td>36.2</td></tr><tr><td>Heard of PITC</td><td> </td><td> </td></tr><tr><td> Yes </td><td>345 </td><td>63.7 </td></tr><tr><td> No</td><td>197</td><td>36.3</td></tr><tr><td>Heard about MTCT </td><td> </td><td> </td></tr><tr><td> Yes </td><td>458 </td><td>84.5 </td></tr><tr><td> No</td><td>84</td><td>15.5</td></tr><tr><td>Know the means of transmission on MTCT (<i>n</i> = 458)</td><td> </td><td> </td></tr><tr><td> During pregnancy</td><td>309 </td><td>67.5 </td></tr><tr><td> During labor/delivery</td><td>324 </td><td>70.7</td></tr><tr><td> During breast feeding</td><td>251 </td><td>54.8</td></tr><tr><td>Exact timing of MTCT answered by women</td><td> </td><td> </td></tr><tr><td> None</td><td>84</td><td> 15.5 </td></tr><tr><td> One</td><td>130 </td><td>24.0 </td></tr><tr><td> Two</td><td>225 </td><td>41.5 </td></tr><tr><td> Three</td><td>103 </td><td>19.0 </td></tr></table> |
606a996870cc9a2cad5a64ebdccb7ccbcfaf139f9088e7ed93213c060b13f5b5.png | simple | <table><tr><td> </td><td>No. of contigs with hits</td><td>No. of unique accessions</td><td>No. of unique protein hits</td></tr><tr><td>Zebrafish RefSeq</td><td>87,931</td><td>19,711</td><td>19,711</td></tr><tr><td>Uniprot/Swiss-Prot</td><td>80,012</td><td>26,396</td><td>17,669</td></tr><tr><td>Total</td><td>94,476</td><td>-</td><td>25,144</td></tr></table> |
5a507e889714939083fc05eb6ba7a3302da5db3ec893314876ca3a234e30925f.png | complex | <table><tr><td></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td><td>Model 5</td></tr><tr><td colspan="6">Segregation</td></tr><tr><td> D <0.6</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> D >0.6</td><td>1.16 (1.13 to 1.19)</td><td>1.19 (1.16 to 1.22)</td><td>1.18 (1.15 to 1.20)</td><td>1.02 (1.00 to 1.05)</td><td>1.03 (1.00 to 1.05)</td></tr><tr><td colspan="6">Gender</td></tr><tr><td> Male</td><td></td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> Female</td><td></td><td>1.91 (1.87 to 1.94)</td><td>1.90 (1.87 to 1.94)</td><td>1.91 (1.88 to 1.95)</td><td>1.91 (1.88 to 1.95)</td></tr><tr><td colspan="6">Age (years)</td></tr><tr><td> 18–24</td><td></td><td>1.00</td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> 25–34</td><td></td><td>2.29 (2.18 to 2.41)</td><td>2.29 (2.18 to 2.41)</td><td>2.28 (2.17 to 2.39)</td><td>2.28 (2.16 to 2.39)</td></tr><tr><td> 35–44</td><td></td><td>4.11 (3.92 to 4.31)</td><td>4.12 (3.93 to 4.32)</td><td>4.26 (4.06 to 4.46)</td><td>4.26 (4.06 to 4.47)</td></tr><tr><td> 45–54</td><td></td><td>5.50 (5.25 to 5.76)</td><td>5.51 (5.26 to 5.78)</td><td>5.74 (5.48 to 6.02)</td><td>5.75 (5.49 to 6.02)</td></tr><tr><td> 55–64</td><td></td><td>6.70 (6.39 to 7.02)</td><td>6.72 (6.41 to 7.04)</td><td>7.00 (6.68 to 7.34)</td><td>7.00 (6.68 to 7.34)</td></tr><tr><td> 65–74</td><td></td><td>7.72 (7.36 to 8.10)</td><td>7.73 (7.37 to 8.11)</td><td>7.96 (7.59 to 8.35)</td><td>7.96 (7.58 to 8.35)</td></tr><tr><td colspan="6">Conurbation</td></tr><tr><td> Rural</td><td></td><td></td><td>1.00</td><td>1.00</td><td>1.00</td></tr><tr><td> Urban</td><td></td><td></td><td>1.48 (1.41 to 1.55)</td><td>1.20 (1.14 to 1.25)</td><td>1.18 (1.12 to 1.24)</td></tr><tr><td colspan="6">Deprivation</td></tr><tr><td> 1—most affluent</td><td></td><td></td><td></td><td>1.00</td><td>1.00</td></tr><tr><td> 2</td><td></td><td></td><td></td><td>1.32 (1.28 to 1.36)</td><td>1.27 (1.23 to 1.32)</td></tr><tr><td> 3</td><td></td><td></td><td></td><td>1.62 (1.60 to 1.68)</td><td>1.55 (1.49 to 1.60)</td></tr><tr><td> 4</td><td></td><td></td><td></td><td>2.10 (2.03 to 2.17)</td><td>1.94 (1.87 to 2.02)</td></tr><tr><td> 5—most deprived</td><td></td><td></td><td></td><td>2.91 (2.82 to 3.01)</td><td>2.67 (2.57 to 2.78)</td></tr><tr><td colspan="6">Crime</td></tr><tr><td> 1—low crime</td><td></td><td></td><td></td><td></td><td>1.00</td></tr><tr><td> 2</td><td></td><td></td><td></td><td></td><td>1.12 (1.08 to 1.16)</td></tr><tr><td> 3</td><td></td><td></td><td></td><td></td><td>1.16 (1.12 to 1.20)</td></tr><tr><td> 4</td><td></td><td></td><td></td><td></td><td>1.17 (1.13 to 1.22)</td></tr><tr><td> 5—high crime</td><td></td><td></td><td></td><td></td><td>1.22 (1.17 to 1.26)</td></tr></table> |
2e7fc7afaef9893d338eccf96ab7788bb333fa2141cc258a73d6e6c9b1448a09.png | simple | <table><tr><td>Parameters</td><td>Results</td></tr><tr><td>Weight (g)</td><td>24.9±3.1</td></tr><tr><td>Peak CSA [ mm<sup>2</sup>]</td><td> </td></tr><tr><td>Cartesian Measurement</td><td>0.75±0.05</td></tr><tr><td>Radial Triggered Measurement</td><td>0.75±0.04</td></tr><tr><td>Retrospective Measurement</td><td>0.73±0.04</td></tr><tr><td>Peak volume flow [ cm<sup>3</sup>/s]</td><td> </td></tr><tr><td>Cartesian Measurement</td><td>0.27±0.04</td></tr><tr><td>Radial Triggered Measurement</td><td>0.28±0.03</td></tr><tr><td>Retrospective Measurement</td><td>0.28±0.04</td></tr><tr><td>PWV [m/s]</td><td> </td></tr><tr><td>Cartesian Measurement</td><td>2.4±0.2</td></tr><tr><td>Radial Triggered Measurement</td><td>2.3±0.2</td></tr><tr><td>Retrospective Measurement</td><td>2.3±0.2</td></tr></table> |
4ce349a7ade9b5440555d30ba788c28f188783fb2df3aef1aeec48a232fd2b7f.png | simple | <table><tr><td>Chiropractor ID</td><td>Number of diagnoses coded</td><td>Agreement on *<i>rubric level</i>(%)</td><td>Agreement on **<i>term level</i>(%)</td></tr><tr><td>1</td><td>9</td><td>89</td><td>67</td></tr><tr><td>2</td><td>20</td><td>15</td><td>10</td></tr><tr><td>3</td><td>12</td><td>92</td><td>50</td></tr><tr><td>4</td><td>15</td><td>60</td><td>0</td></tr><tr><td>5</td><td>14</td><td>29</td><td>29</td></tr><tr><td>6</td><td>9</td><td>67</td><td>56</td></tr><tr><td>7</td><td>14</td><td>29</td><td>7</td></tr><tr><td>8</td><td>10</td><td>100</td><td>100</td></tr><tr><td>9</td><td>16</td><td>44</td><td>31</td></tr><tr><td>10</td><td>11</td><td>82</td><td>73</td></tr><tr><td>11</td><td>10</td><td>100</td><td>10</td></tr><tr><td>12</td><td>11</td><td>27</td><td>18</td></tr><tr><td>13</td><td>12</td><td>0</td><td>0</td></tr><tr><td>14</td><td>4</td><td>75</td><td>0</td></tr><tr><td>Overall agreement %</td><td></td><td>52</td><td>35</td></tr><tr><td>Agreement expected by chance</td><td></td><td>17</td><td>6</td></tr><tr><td>Overall agreement (Cohen’s Kappa)</td><td>Total number of codes: 167</td><td>0.4 (95% CI 0.3-0.7)***</td><td>0.3 (95% CI 0.2-0.5)***</td></tr></table> |
51dfd4004f08dc231414aba54609a2cafb3674cda66c8be838896d8d9cbcaefc.png | simple | <table><tr><td>Measure</td><td>Sample size</td><td>Mean score (SD)</td></tr><tr><td>Adverse childhood experience (ACE) score</td><td><i>n</i> = 67</td><td>1.93 (2.45)</td></tr><tr><td>ACE <i>z</i>-score</td><td><i>n</i> = 67</td><td>0.053 (0.94)</td></tr><tr><td>ACE (range)</td><td><i>n</i> = 67</td><td>0.00–10.00</td></tr></table> |
a18a5a4606da740b913730325f95ca2ce0f149cc8bb406b6bc2f4377026f43d8.png | complex | <table><tr><td rowspan="2">Cyanotoxins</td><td colspan="2">Water</td><td colspan="2">Fish</td><td colspan="2">Plant</td><td>Percent of detections</td></tr><tr><td>2009</td><td>2010</td><td>2009</td><td>2010</td><td>2009</td><td>2010</td><td>2009–2010</td></tr><tr><td>BMAA</td><td>13</td><td>12</td><td>22</td><td>9</td><td>5</td><td>5</td><td>18%</td></tr><tr><td>DABA</td><td>13</td><td>12</td><td>19</td><td>7</td><td>5</td><td>5</td><td>17%</td></tr><tr><td>Anatoxin-<i>a</i></td><td>13</td><td>18</td><td>0</td><td>0</td><td>5</td><td>5</td><td>12%</td></tr><tr><td>Total samples</td><td>31</td><td>36</td><td>115</td><td>133</td><td>36</td><td>36</td><td>387</td></tr></table> |
64bbc60fce6acf564fdb21156bfa023eef6fdac0f0f95effe006048becd3cd44.png | simple | <table><tr><td>Prevalence (%)</td><td>Men</td><td>Women</td><td>Total</td></tr><tr><td>Diabetes</td><td>14.0</td><td>10.0</td><td>11.6</td></tr><tr><td>Dyslipidemia</td><td>27.4</td><td>34.8</td><td>31.8</td></tr><tr><td>Hypertension</td><td>30.2</td><td>36.2</td><td>33.7</td></tr><tr><td>Smoking</td><td>12.6</td><td>7.9</td><td>9.8</td></tr><tr><td>Obesity</td><td>17.3</td><td>21.5</td><td>19.8</td></tr></table> |
af566d8604c4673e400eca8a59f84739ebd303e79d03c368cd1b1a879a002e37.png | complex | <table><tr><td>Demographics</td><td>Baseline</td><td>Follow-up</td></tr><tr><td>Male, n</td><td>19 (61%)</td><td></td></tr><tr><td colspan="3">Mean age + −SD, years 70.2 (SD 11.7)</td></tr><tr><td>< 9 years of education</td><td>5 (16%)</td><td></td></tr><tr><td colspan="3">Stroke subtype</td></tr><tr><td> Cerebral infarction</td><td>29 (94%)</td><td></td></tr><tr><td> TIA</td><td>2 (6%)</td><td></td></tr><tr><td colspan="3">Risk factors, n</td></tr><tr><td> Hypertension</td><td>20 (65%)</td><td></td></tr><tr><td> Hyperlipideamia</td><td>23 (74%)</td><td></td></tr><tr><td> Diabetes</td><td>6 (19%)</td><td></td></tr><tr><td> Current smoking</td><td>7 (23%)</td><td></td></tr><tr><td> Atrial fibrillation</td><td>3 (10%)</td><td></td></tr><tr><td> BMI</td><td>18 (58%)</td><td></td></tr><tr><td colspan="3">TOAST classification, n</td></tr><tr><td> Large-vessel disease</td><td>2 (7%)</td><td></td></tr><tr><td> Cardio-embolic disease</td><td>2 (6%)</td><td></td></tr><tr><td> Small vessel disease</td><td>17 (55%)</td><td></td></tr><tr><td> Stroke of undetermined aetiology</td><td>10 (32%)</td><td></td></tr><tr><td colspan="3">OCSP classification, n</td></tr><tr><td> TACI</td><td>0</td><td></td></tr><tr><td> PACI</td><td>13 (42%)</td><td></td></tr><tr><td> LACI</td><td>15 (48%)</td><td></td></tr><tr><td> POCI</td><td>3 (10%)</td><td></td></tr><tr><td colspan="3">Assessments</td></tr><tr><td> NIHSS, day 1, mean (IQR)</td><td>3.06 (1.0-4.0)</td><td>0.58 (0.0-1.0)</td></tr><tr><td> BI, mean(IQR)</td><td>18.5 (19.5-20.0)</td><td>19.48 (20.0-20.0)</td></tr><tr><td> mRS, mean (IQR)</td><td>1.35 (0.0-3.0)</td><td>1.06 (1.0-1.0)</td></tr><tr><td> Total TAU, mean (IQR)</td><td></td><td>363 (227–382)</td></tr><tr><td> Apoɛ4</td><td>9 (29%)</td><td></td></tr><tr><td> TMT A (seconds) (SD)</td><td>86.0 (±97.0)</td><td>61.6 (±48.4)</td></tr><tr><td> MMSE (points) (SD)</td><td>26.0 (±3.8)</td><td>26.7 (±3.9)</td></tr><tr><td> 10 word test (words)</td><td>20.1 (±6.8)</td><td>24.5 (±6.1)</td></tr><tr><td> Ventricular volume (mm^3)(SD)</td><td>60,796 (±17,339)</td><td>60,334 (±25,118)</td></tr><tr><td> Global brain volume(mm^3) (SD)</td><td>1,404,660 (±63,160)</td><td>1,368,194 (±142,856)</td></tr></table> |
b251cc912c3818ddc705858a928f77516ca0768994860f8783502dde8e18b4be.png | complex | <table><tr><td>Dimension</td><td>F</td><td>BMS</td><td>WMS</td><td>ICC1</td><td>ICC2</td><td>η2</td><td>ω2</td><td>PROB</td></tr><tr><td colspan="9">UNIT LEVEL AGGREGATION</td></tr><tr><td>Leadership</td><td>2.1733</td><td>0.7596</td><td>0.3495</td><td>0.0768</td><td>0.5399</td><td>0.1417</td><td>0.0765</td><td>0.0000</td></tr><tr><td>Culture</td><td>2.9261</td><td>0.7410</td><td>0.2533</td><td>0.1201</td><td>0.6582</td><td>0.1814</td><td>0.1193</td><td>0.0000</td></tr><tr><td>Evaluation</td><td>2.3907</td><td>0.7391</td><td>0.3092</td><td>0.0897</td><td>0.5817</td><td>0.1540</td><td>0.0895</td><td>0.0000</td></tr><tr><td>Social Capital</td><td>1.7570</td><td>0.4074</td><td>0.2319</td><td>0.0509</td><td>0.4308</td><td>0.1181</td><td>0.0508</td><td>0.0000</td></tr><tr><td>Formal Interactions</td><td>1.5716</td><td>0.8838</td><td>0.5624</td><td>0.0389</td><td>0.3637</td><td>0.1064</td><td>0.0387</td><td>0.0009</td></tr><tr><td>Informal Interactions</td><td>1.3070</td><td>3.3072</td><td>2.5304</td><td>0.0213</td><td>0.2349</td><td>0.0906</td><td>0.0213</td><td>0.0342</td></tr><tr><td>Structural and Electronic Resources</td><td>2.5201</td><td>6.8517</td><td>2.7189</td><td>0.0972</td><td>0.6032</td><td>0.1612</td><td>0.0972</td><td>0.0000</td></tr><tr><td>OS-staff</td><td>7.8907</td><td>7.3179</td><td>0.9274</td><td>0.3281</td><td>0.8733</td><td>0.3728</td><td>0.3254</td><td>0.0000</td></tr><tr><td>OS-space</td><td>7.7267</td><td>5.4560</td><td>0.7061</td><td>0.3228</td><td>0.8706</td><td>0.3685</td><td>0.3207</td><td>0.0000</td></tr><tr><td>OS-time</td><td>4.9345</td><td>2.8298</td><td>0.5735</td><td>0.2180</td><td>0.7973</td><td>0.2724</td><td>0.2170</td><td>0.0000</td></tr><tr><td colspan="9">NURSING HOME LEVEL AGGREGATION</td></tr><tr><td>Leadership</td><td>3.7238</td><td>1.3391</td><td>0.3596</td><td>0.0521</td><td>0.7315</td><td>0.0682</td><td>0.0498</td><td>0.0000</td></tr><tr><td>Culture</td><td>7.0012</td><td>1.8055</td><td>0.2579</td><td>0.1079</td><td>0.8572</td><td>0.1205</td><td>0.1032</td><td>0.0000</td></tr><tr><td>Evaluation</td><td>4.5091</td><td>1.4341</td><td>0.3181</td><td>0.0661</td><td>0.7782</td><td>0.0815</td><td>0.0634</td><td>0.0000</td></tr><tr><td>Social Capital</td><td>3.2422</td><td>0.7592</td><td>0.2342</td><td>0.0432</td><td>0.6916</td><td>0.0600</td><td>0.0415</td><td>0.0000</td></tr><tr><td>Formal Interactions</td><td>2.6004</td><td>1.4760</td><td>0.5676</td><td>0.0313</td><td>0.6154</td><td>0.0485</td><td>0.0298</td><td>0.0000</td></tr><tr><td>Informal Interactions</td><td>2.0836</td><td>5.2765</td><td>2.5324</td><td>0.0214</td><td>0.5201</td><td>0.0394</td><td>0.0205</td><td>0.0017</td></tr><tr><td>Structural and Electronic Resources</td><td>5.8401</td><td>16.0841</td><td>2.7541</td><td>0.0889</td><td>0.8288</td><td>0.1032</td><td>0.0855</td><td>0.0000</td></tr><tr><td>OS-staff</td><td>23.9814</td><td>22.9152</td><td>0.9555</td><td>0.3166</td><td>0.9583</td><td>0.3184</td><td>0.3050</td><td>0.0000</td></tr><tr><td>OS-space</td><td>22.1040</td><td>16.3660</td><td>0.7404</td><td>0.2985</td><td>0.9548</td><td>0.3015</td><td>0.2877</td><td>0.0000</td></tr><tr><td>OS-time</td><td>14.6247</td><td>8.4892</td><td>0.5805</td><td>0.2155</td><td>0.9316</td><td>0.2229</td><td>0.2075</td><td>0.0000</td></tr></table> |
b49cb139cabae29b7fdcb2122cf57e7de15bf5d5e340f884d02a771f1aa34224.png | complex | <table><tr><td rowspan="2">Sample</td><td rowspan="2">N (mmol/g)</td><td rowspan="2">C (mmol/g)</td><td rowspan="2">Molar ratio of C/N</td><td colspan="4">CO<sub>2</sub> adsorption capacity (mmol/g)</td><td colspan="4">Amine efficiency</td></tr><tr><td>25 °C</td><td>30 °C</td><td>50 °C</td><td>75 °C</td><td>25 °C</td><td>30 °C</td><td>50 °C</td><td>75 °C</td></tr><tr><td>APS/LDHs</td><td>3.89</td><td>25.62</td><td>6.58</td><td>1.55</td><td>2.05</td><td>2.09</td><td>1.86</td><td>0.40</td><td>0.53</td><td>0.54</td><td>0.48</td></tr></table> |
a097d249c29333b077422b11dc62f9f6511f247fbe999c569c2544ac2a0565aa.png | simple | <table><tr><td><i>Gene</i></td><td><i>ENSEMBL ID</i></td><td><i>ENSEMBL description</i></td></tr><tr><td>Acot7</td><td>ENSMUSG00000028937</td><td>acyl-CoA thioesterase 7 [Acc:MGI:1917275]</td></tr><tr><td>Ankrd13d</td><td>ENSMUSG00000005986</td><td>ankyrin repeat domain 13 family, member D [Acc:MGI:1915673]</td></tr><tr><td>Aplp1</td><td>ENSMUSG00000006651</td><td>amyloid beta (A4) precursor-like protein 1 [Acc:MGI:88046]</td></tr><tr><td>Atp1a3</td><td>ENSMUSG00000040907</td><td>ATPase, Na+/K+ transporting, alpha 3 polypeptide [Acc:MGI:88107]</td></tr><tr><td>Atp6v1a</td><td>ENSMUSG00000052459</td><td>ATPase, H+ transporting, lysosomal V1 subunit A [Acc:MGI:1201780]</td></tr><tr><td>Atp6v1d</td><td>ENSMUSG00000021114</td><td>ATPase, H+ transporting, lysosomal V1 subunit D [Acc:MGI:1921084]</td></tr><tr><td>Calm3</td><td>ENSMUSG00000019370</td><td>calmodulin 3 [Acc:MGI:103249]</td></tr><tr><td>Cdh13</td><td>ENSMUSG00000031841</td><td>cadherin 13 [Acc:MGI:99551]</td></tr><tr><td>Cyfip2</td><td>ENSMUSG00000020340</td><td>cytoplasmic FMR1 interacting protein 2 [Acc:MGI:1924134]</td></tr><tr><td>Dos</td><td>ENSMUSG00000035640</td><td>downstream of Stk11 [Acc:MGI:1354170]</td></tr><tr><td>Dusp26</td><td>ENSMUSG00000039661</td><td>dual specificity phosphatase 26 (putative) [Acc:MGI:1914209]</td></tr><tr><td>Gprasp1</td><td>ENSMUSG00000043384</td><td>G protein-coupled receptor associated sorting protein 1 [Acc:MGI:1917418]</td></tr><tr><td>Gria1</td><td>ENSMUSG00000020524</td><td>glutamate receptor, ionotropic, AMPA1 (alpha 1) [Acc:MGI:95808]</td></tr><tr><td>Grina</td><td>ENSMUSG00000022564</td><td>glutamate receptor, ionotropic, N-methyl D-asparate-associated protein 1 [Acc:MGI:1913418]</td></tr><tr><td>Hdac11</td><td>ENSMUSG00000034245</td><td>histone deacetylase 11 [Acc:MGI:2385252]</td></tr><tr><td>Kifap3</td><td>ENSMUSG00000026585</td><td>kinesin-associated protein 3 [Acc:MGI:107566]</td></tr><tr><td>Kns2</td><td>ENSMUSG00000021288</td><td>kinesin 2 [Acc:MGI:107978]</td></tr><tr><td>Ndrg4</td><td>ENSMUSG00000036564</td><td>N-myc downstream regulated gene 4 [Acc:MGI:2384590]</td></tr><tr><td>Pcdh17</td><td>ENSMUSG00000035566</td><td>protocadherin 17 [Acc:MGI:2684924]</td></tr><tr><td>Pfkm</td><td>ENSMUSG00000033065</td><td>phosphofructokinase, muscle [Acc:MGI:97548]</td></tr><tr><td>Phactr1</td><td>ENSMUSG00000054728</td><td>phosphatase and actin regulator 1 [Acc:MGI:2659021]</td></tr><tr><td>Pja2</td><td>ENSMUSG00000024083</td><td>praja 2, RING-H2 motif containing [Acc:MGI:2159342]</td></tr><tr><td>Ppp2r2c</td><td>ENSMUSG00000029120</td><td>protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform [Acc:MGI:2442660]</td></tr><tr><td>Prkacb</td><td>ENSMUSG00000005034</td><td>protein kinase, cAMP dependent, catalytic, beta [Acc:MGI:97594]</td></tr><tr><td>Rogdi</td><td>ENSMUSG00000022540</td><td>rogdi homolog (Drosophila) [Acc:MGI:1913299]</td></tr><tr><td>Rusc1</td><td>ENSMUSG00000041263</td><td>RUN and SH3 domain containing 1 [Acc:MGI:1919546]</td></tr><tr><td>Scamp5</td><td>ENSMUSG00000040722</td><td>secretory carrier membrane protein 5 [Acc:MGI:1928948]</td></tr><tr><td>Slc25a4</td><td>ENSMUSG00000031633</td><td>solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 [Acc:MGI:1353495]</td></tr><tr><td>Stx1b2</td><td>ENSMUSG00000030806</td><td>syntaxin 1B2 [Acc:MGI:1930705]</td></tr><tr><td>Sult4a1</td><td>ENSMUSG00000018865</td><td>sulfotransferase family 4A, member 1 [Acc:MGI:1888971]</td></tr><tr><td>Sv2a</td><td>ENSMUSG00000038486</td><td>synaptic vesicle glycoprotein 2 a [Acc:MGI:1927139]</td></tr><tr><td>Syngr3</td><td>ENSMUSG00000007021</td><td>synaptogyrin 3 [Acc:MGI:1341881]</td></tr><tr><td>Tspyl4</td><td>ENSMUSG00000039485</td><td>TSPY-like 4 [Acc:MGI:106393]</td></tr><tr><td>Vamp2</td><td>ENSMUSG00000020894</td><td>vesicle-associated membrane protein 2 [Acc:MGI:1313277]</td></tr><tr><td>Wbp2</td><td>ENSMUSG00000034341</td><td>WW domain binding protein 2 [Acc:MGI:104709]</td></tr><tr><td>Wsb2</td><td>ENSMUSG00000029364</td><td>WD repeat and SOCS box-containing 2 [Acc:MGI:2144041]</td></tr><tr><td>0710005I19Rik</td><td>ENSMUSG00000041141</td><td>RIKEN cDNA 0710005I19 gene [Acc:MGI:1918941]</td></tr><tr><td>2900002G04Rik</td><td>ENSMUSG00000041020</td><td>RIKEN cDNA 2900002G04 gene [Acc:MGI:1917474]</td></tr><tr><td>2900011O08Rik</td><td>ENSMUSG00000044117</td><td>RIKEN cDNA 2900011O08 gene [Acc:MGI:1914504]</td></tr><tr><td>5330410G16Rik</td><td>ENSMUSG00000035964</td><td>RIKEN cDNA 5330410G16 gene [Acc:MGI:1915187]</td></tr><tr><td>A030009H04Rik</td><td>ENSMUSG00000043419</td><td>RIKEN cDNA A030009H04 gene [Acc:MGI:1915359]</td></tr></table> |
5b93c5683ce555aace4547c7020fbde69662cd5415f2f9b7cf91142df695cfd1.png | complex | <table><tr><td rowspan="3">Week</td><td colspan="4">Multivariate 1*</td><td colspan="4">Multivariate 2**</td></tr><tr><td colspan="2">BMI <18.5</td><td colspan="2">BMI ≥18.5</td><td colspan="2">BMI <18.5</td><td colspan="2">BMI ≥18.5</td></tr><tr><td><i>β</i></td><td><i>P</i> value</td><td><i>β</i></td><td><i>P</i> value</td><td><i>β</i></td><td><i>P</i> value</td><td><i>β</i></td><td><i>P</i> value</td></tr><tr><td>8</td><td>−4.076</td><td>0.347</td><td>−0.693</td><td>0.802</td><td>−6.761</td><td>0.192</td><td>−3.012</td><td>0.388</td></tr><tr><td>12</td><td>6.357</td><td>0.197</td><td>5.915</td><td>0.090</td><td>5.190</td><td>0.324</td><td>8.878</td><td>0.020</td></tr><tr><td>17</td><td>8.626</td><td>0.024</td><td>2.501</td><td>0.358</td><td>7.279</td><td>0.053</td><td>3.844</td><td>0.148</td></tr><tr><td>19</td><td>5.466</td><td>0.127</td><td>2.119</td><td>0.393</td><td>6.971</td><td>0.067</td><td>4.345</td><td>0.101</td></tr><tr><td>24</td><td>2.414</td><td>0.450</td><td>−0.904</td><td>0.665</td><td>9.649</td><td>0.078</td><td>−0.772</td><td>0.835</td></tr><tr><td>28</td><td>1.344</td><td>0.675</td><td>−1.755</td><td>0.381</td><td>7.352</td><td>0.173</td><td>−5.336</td><td>0.115</td></tr><tr><td>30</td><td>3.224</td><td>0.311</td><td>−2.228</td><td>0.257</td><td>8.083</td><td>0.072</td><td>−4.482</td><td>0.111</td></tr><tr><td colspan="9">Before birth</td></tr><tr><td> 6</td><td>6.484</td><td>0.053</td><td>−3.556</td><td>0.082</td><td>7.263</td><td>0.041</td><td>−5.047</td><td>0.024</td></tr><tr><td> 4</td><td>8.100</td><td>0.025</td><td>−2.021</td><td>0.353</td><td>7.916</td><td>0.026</td><td>−1.380</td><td>0.533</td></tr><tr><td> 2</td><td>8.891</td><td>0.022</td><td>0.334</td><td>0.889</td><td>9.270</td><td>0.014</td><td>1.003</td><td>0.675</td></tr><tr><td>At birth</td><td>7.219</td><td>0.075</td><td>1.659</td><td>0.507</td><td>7.455</td><td>0.061</td><td>2.614</td><td>0.291</td></tr></table> |
be411019cef16eb6024e885e6d683b7e285a6b3dabe1e0af7b51d7c53c0118e8.png | complex | <table><tr><td></td><td colspan="8">Contribution of need and non-need factors to the concentration indices for access to MCH care</td></tr><tr><td></td><td colspan="2">Medical treatment for Diarrhea</td><td colspan="2">Skilled birth attendance</td><td colspan="2">Measles immunization</td><td colspan="2">Modern Contraceptive</td></tr><tr><td></td><td>Absolute</td><td>%</td><td>Absolute</td><td>%</td><td>Absolute</td><td>%</td><td>Absolute</td><td>%</td></tr><tr><td>Need factors</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Demographic</td><td>0.0002</td><td>0.1</td><td>−0.0079</td><td>−1.1</td><td>0.0012</td><td>1.4</td><td>−0.0038</td><td>−1.4</td></tr><tr><td>Health status</td><td>0<sup>a</sup></td><td>0.0</td><td>−0.0072</td><td>−1.0</td><td>-</td><td>-</td><td>0.0000</td><td>0.0</td></tr><tr><td>Subtotal</td><td>0.0002</td><td>0.1</td><td>−0.0151</td><td>−2.1</td><td>0.0012</td><td>1.4</td><td>−0.0038</td><td>−1.4</td></tr><tr><td>Non-need factors</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Wealth index</td><td>0.0510</td><td>33.5</td><td>0.1162</td><td>15.9</td><td>0.0578</td><td>68.2</td><td>0.1605</td><td>58.4</td></tr><tr><td>Educational attainment (women)</td><td>0.0294</td><td>19.3</td><td>0.1779</td><td>24.4</td><td>0.0175</td><td>20.7</td><td>0.0449</td><td>16.4</td></tr><tr><td>Educational attainment (men)</td><td>0.0205</td><td>13.4</td><td>0.0510</td><td>7.0</td><td>−0.0033</td><td>−3.8</td><td>0.0021</td><td>0.8</td></tr><tr><td>Area of residence (rural)</td><td>0.0158</td><td>10.4</td><td>0.2984</td><td>40.9</td><td>−0.0019</td><td>−2.3</td><td>0.0265</td><td>9.7</td></tr><tr><td>Subtotal</td><td>0.1097</td><td>77.0</td><td>0.6434</td><td>88.2</td><td>0.0702</td><td>82.8</td><td>0.2341</td><td>85.2</td></tr><tr><td>Residual</td><td>0.0355</td><td>22.8</td><td>0.1015</td><td>13.9</td><td>0.0134</td><td>15.8</td><td>0.0443</td><td>16.1</td></tr><tr><td>Total</td><td>0.1523</td><td></td><td>0.7299</td><td></td><td>0.0847</td><td></td><td>0.2747</td><td></td></tr><tr><td>Horizontal inequity index</td><td>0.1521</td><td></td><td>0.7450</td><td></td><td>0.0835</td><td></td><td>0.2784</td><td></td></tr><tr><td>Adjusted R<sup>2</sup></td><td>0.05</td><td></td><td>0.35</td><td></td><td>0.13</td><td></td><td>0.21</td><td></td></tr></table> |
724e62da573169a2eec566294e2f5ca9d13134aa7864da5e8dc0c51300bfa511.png | simple | <table><tr><td>Rank</td><td>IF range</td><td>China (%)</td><td>USA (%)</td><td>UK (%)</td><td>Germany (%)</td><td>Japan (%)</td><td>South Korea (%)</td></tr><tr><td>Top 25%</td><td>11.089-4.046</td><td>809(27.67)</td><td>16901(51.63)</td><td>2973(54.52)</td><td>3583(47.91)</td><td>2170(34.19)</td><td>426(30.15)</td></tr><tr><td>Top 25%-50%</td><td>3.693-2.462</td><td>942(32.22)</td><td>10815(33.04)</td><td>1383(25.36)</td><td>1951(26.09)</td><td>1486(23.41)</td><td>415(29.37)</td></tr><tr><td>Bottom25%-50%</td><td>2.427-1.679</td><td>770(26.33)</td><td>3204(9.79)</td><td>598(10.97)</td><td>1310(17.52)</td><td>1726(27.19)</td><td>376(26.61)</td></tr><tr><td>Bottom 25%</td><td>1.590-0.101</td><td>403(13.78)</td><td>1812(5.54)</td><td>499(9.15)</td><td>635(8.49)</td><td>965(15.20)</td><td>196(13.87)</td></tr></table> |
63058852436003aacfaaf8d8485fdf7faa5b545c3589164b74e8e34151a6b647.png | simple | <table><tr><td> </td><td>PDGF<i>α</i>R</td><td>GalC</td><td>MBP</td></tr><tr><td>Control</td><td>0.43 ± 0.07</td><td>0.40 ± 0.09</td><td>0.49 ± 0.07</td></tr><tr><td>NSCs </td><td>0.90 ± 0.11<sup><i>∗</i></sup></td><td>0.74 ± 0.09<sup><i>∗</i></sup></td><td>1.10 ± 0.14<sup><i>∗</i></sup></td></tr><tr><td>T3/NSCs </td><td>1.42 ± 0.10<sup><i>∗</i>#</sup></td><td>1.50 ± 0.09<sup><i>∗</i>#</sup></td><td>1.43 ± 0.10<sup><i>∗</i>#</sup></td></tr><tr><td>GDNF-T3/NSCs </td><td>1.52 ± 0.09<sup><i>∗</i>#</sup></td><td>1.69 ± 0.08<sup><i>∗</i>#<i>ψ</i></sup></td><td>1.62 ± 0.10<sup><i>∗</i>#<i>ψ</i></sup></td></tr></table> |
170aef6dfaf5d2e903e01b1ce7d56e481c7640a2a0b1b85f5ef554ced1291d56.png | simple | <table><tr><td>Generic name</td><td>Score</td><td>Information from DrugBank<sup>b</sup></td><td>Information from other sources</td></tr><tr><td>Dexamethasone</td><td>22.1</td><td>An anti-inflammatory 9-fluoro-glucocorticoid.</td><td>Dexamethasone was reported to have a dramatic life-saving effect on people with cerebral malaria[44]. However, two subsequent placebo-controlled clinical trials failed to demonstrate clinical benefit[45,46].</td></tr><tr><td>Verapamil</td><td>21.5</td><td>A calcium channel blocker for hypertension, angina, and cluster headache prophylaxis.</td><td>A 1995 study[48] reported that verapamil reverses chloroquine resistance in the malaria parasite.</td></tr><tr><td>Quercetin</td><td>18.9</td><td>A flavonol found in plants, antioxidant.</td><td>A 2012 study[47] reported that quercetin had antiplasmodial activity.</td></tr><tr><td>Miconazole</td><td>16.5</td><td>An imidazole antifungal agent.</td><td>Many studies[39-43] have reported antimalarial activities of antifungal azole compounds.</td></tr><tr><td>Clotrimazole</td><td>15.9</td><td>An imidazole derivative with a broad spectrum of antimycotic activity.</td><td>Many studies[39-43] have reported antimalarial activities of azoles, including clotrimazole[43].</td></tr><tr><td>Cimetidine</td><td>15.5</td><td>For acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion.</td><td>A 1997 study[49] reported synergism of cimetidine with antimalarial agents. It is ineffective when used alone.</td></tr><tr><td>Ketoconazole</td><td>15.2</td><td>For systemic fungal infections.</td><td>Many studies[39-43] have reported antimalarial activities of azoles, including ketoconazole[41].</td></tr><tr><td>Nifedipine</td><td>14.9</td><td>A calcium channel blocker for angina, hypertension, and Raynaud's phenomenon.</td><td> </td></tr><tr><td>Tamoxifen</td><td>14.4</td><td>For breast cancer.</td><td> </td></tr><tr><td>Clobetasol</td><td>14.4</td><td>For corticosteroid-responsive dermatoses of the scalp.</td><td> </td></tr></table> |
980bf9022191d8933d7dbb7c0ec37c769050ae6a834d631079d73732395b323d.png | simple | <table><tr><td> </td><td> </td><td>Ethanol (g/L)</td><td>Yield (g/g)</td><td>Xylose (g/L/h)</td><td>Ethanol (g/L/h)</td><td>Time (h)</td></tr><tr><td>ScF2</td><td>Pre-G</td><td>52.25 ± 1.48</td><td>0.40 ± 0.01</td><td>1.10 ± 0.00</td><td>0.44 ± 0.01</td><td>120</td></tr><tr><td> </td><td>Pre-X</td><td>50.20 ± 1.78</td><td>0.37 ± 0.01</td><td>1.28 ± 0.01</td><td>0.52 ± 0.02</td><td>96</td></tr><tr><td><i>P stipitis</i></td><td>Pre-G</td><td>52.15 ± 0.28</td><td>0.38 ± 0.00</td><td>0.95 ± 0.01</td><td>0.36 ± 0.00</td><td>144</td></tr><tr><td> </td><td>Pre-X</td><td>49.94 ± 0.62</td><td>0.37 ± 0.01</td><td>0.93 ± 0.01</td><td>0.35 ± 0.00</td><td>144</td></tr></table> |
e9b074eac0ce1cb4f01f7ddcd9a536e1e7cd91626bfd0c98dff90aa87983c196.png | complex | <table><tr><td rowspan="2">Miracidia<sup>1</sup></td><td rowspan="2">Mean<sup>2</sup></td><td rowspan="2">Std. Error</td><td colspan="2">95% CI</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td>Mwea<i>B. pfeifferi</i>x Mwea<i>S. mansoni</i></td><td></td><td></td><td></td><td></td></tr><tr><td>1 miracidium</td><td>7.66</td><td>0.80</td><td>6.09</td><td>9.23</td></tr><tr><td>5 miracidia</td><td>6.18</td><td>0.80</td><td>4.61</td><td>7.75</td></tr><tr><td>10 miracidia</td><td>4.04</td><td>0.43</td><td>3.20</td><td>4.88</td></tr><tr><td>25 miracidia</td><td>4.14</td><td>0.55</td><td>3.05</td><td>5.23</td></tr><tr><td>Overall</td><td>5.51</td><td>0.35</td><td>4.83</td><td>6.18</td></tr><tr><td>Mwea<i>B. pfeifferi</i>x Asao<i>S. mansoni</i></td><td></td><td></td><td></td><td></td></tr><tr><td>1 miracidium</td><td>5.10</td><td>0.58</td><td>3.96</td><td>6.24</td></tr><tr><td>5 miracidia</td><td>5.34</td><td>0.38</td><td>4.59</td><td>6.09</td></tr><tr><td>10 miracidia</td><td>3.94</td><td>0.26</td><td>3.43</td><td>4.45</td></tr><tr><td>25 miracidia</td><td>4.40</td><td>0.37</td><td>3.68</td><td>5.12</td></tr><tr><td>Overall</td><td>4.70</td><td>0.21</td><td>4.28</td><td>5.11</td></tr><tr><td>Asao<i>B. pfeifferi</i>x Mwea<i>S. mansoni</i></td><td></td><td></td><td></td><td></td></tr><tr><td>1 miracidium</td><td>14.42</td><td>1.34</td><td>11.80</td><td>17.04</td></tr><tr><td>5 miracidia</td><td>13.52</td><td>0.88</td><td>11.80</td><td>15.24</td></tr><tr><td>10 miracidia</td><td>12.44</td><td>1.18</td><td>10.13</td><td>14.75</td></tr><tr><td>25 miracidia</td><td>10.30</td><td>0.69</td><td>8.95</td><td>11.65</td></tr><tr><td>Overall</td><td>12.68</td><td>0.54</td><td>11.63</td><td>13.73</td></tr><tr><td>Asao<i>B. pfeifferi</i>x Asao<i>S. mansoni</i></td><td></td><td></td><td></td><td></td></tr><tr><td>1 miracidium</td><td>12.70</td><td>1.35</td><td>10.05</td><td>15.35</td></tr><tr><td>5 miracidia</td><td>14.18</td><td>1.26</td><td>11.71</td><td>16.65</td></tr><tr><td>10 miracidia</td><td>9.62</td><td>1.25</td><td>7.17</td><td>12.07</td></tr><tr><td>25 miracidia</td><td>10.98</td><td>1.49</td><td>8.06</td><td>13.90</td></tr><tr><td>Overall</td><td>12.06</td><td>0.70</td><td>10.68</td><td>13.44</td></tr><tr><td>Overall analysis</td><td></td><td></td><td></td><td></td></tr><tr><td>Negative control</td><td>18.34</td><td>0.86</td><td>16.65</td><td>20.03</td></tr><tr><td>1 miracidium</td><td>9.97</td><td>0.60</td><td>8.80</td><td>11.14</td></tr><tr><td>5 miracidium</td><td>9.81</td><td>0.53</td><td>8.78</td><td>10.84</td></tr><tr><td>10 miracidia</td><td>7.51</td><td>0.52</td><td>6.50</td><td>8.52</td></tr><tr><td>25 miracidia</td><td>7.46</td><td>0.50</td><td>6.48</td><td>8.43</td></tr></table> |
c923c8d993a4df33bb14ebeb33d58def297ced79fef86db480f16f4967f2dafd.png | simple | <table><tr><td>X<sup>2</sup></td><td>p Value</td><td>Odds Ratio 95% CI</td><td>Genotype/Allele</td></tr><tr><td>TT Vs TC + CC</td><td>3.31</td><td>0.06</td><td>0.71(0.5015-1.026)</td></tr><tr><td>TC Vs TT+CC</td><td>0.28</td><td>0.59</td><td>1.10(0.7752-1.563)</td></tr><tr><td>CCVs TC + TT</td><td>4.51</td><td>0.03</td><td>1.94(1.044-3.605)</td></tr><tr><td>C Vs T</td><td>5.12</td><td>0.02</td><td>1.35(1.041-1.758)</td></tr><tr><td>T Vs C</td><td>5.12</td><td>0.02</td><td>0.73(0.56-0.960)</td></tr></table> |
8d06cdd3f774981da6e049edc919f63a1b117a50aecc10eed3beaa82b5231b8a.png | simple | <table><tr><td>Variables</td><td></td><td></td></tr><tr><td>During the next 3 months</td><td>Measured Scale</td><td>Reliability coefficient</td></tr><tr><td>Self-efficacy</td><td>Very unlikely/very likely</td><td>.35<sup>a</sup></td></tr><tr><td>I would be able to participate regularly in one or more physical activities even if...</td><td></td><td></td></tr><tr><td> 1-I have little free time</td><td></td><td></td></tr><tr><td> 2-I am not carrying excess body weight</td><td></td><td></td></tr><tr><td>Anticipated Regret</td><td>Very unlikely/very likely</td><td>.80<sup>b</sup></td></tr><tr><td>During the next 3 months, if I do not participate in one or more physical activities...</td><td></td><td></td></tr><tr><td> 1-This will bother me</td><td></td><td></td></tr><tr><td> 2-I will regret it</td><td></td><td></td></tr><tr><td> 3-I will worry about it</td><td></td><td></td></tr><tr><td>Positive Feeling</td><td>Very unlikely/very likely</td><td>.52<sup>a</sup></td></tr><tr><td>If I participate in one or more physical activities...</td><td></td><td></td></tr><tr><td> 1-I will be proud</td><td></td><td></td></tr><tr><td> 2-I would be satisfied</td><td></td><td></td></tr><tr><td>Moral Norm</td><td>Strongly disagree/strongly agree</td><td>.80<sup>b</sup></td></tr><tr><td> 1-It is in my principles to participate in one or more physical activities</td><td></td><td></td></tr><tr><td> 2-To participate in one or more physical activities would be acting in accordance with my personal values</td><td></td><td></td></tr><tr><td> 3-It would be against my principles not to participate in one or more physical activities</td><td></td><td></td></tr><tr><td>Descriptive Norm</td><td></td><td></td></tr><tr><td> 1-A lot of people I know participate in one or more physical activities</td><td>Strongly disagree/strongly agree</td><td>.55<sup>a</sup></td></tr><tr><td> 2-Among the 5 persons you know best, how many of them participate in one or more physical activities?</td><td>0 person to 5 people</td><td></td></tr></table> |
681e513cba63946b715b240c4b9085491f06309222c3039afd1dd1102733171c.png | complex | <table><tr><td>Region of location</td><td>Upper East (Talensi- Nabdam and Kassena-Nankana West Districts)</td><td>Form of involvement (initiation, contribution of partners and management of the collaboration)</td><td>Advantages</td><td>Disadvantages</td></tr><tr><td>Interviews conducted</td><td>2 NGO2GHS</td><td rowspan="3">- Dubbed “CIMACS”- Initiated by GHS with CRS as an expert partner/and funder.- An MOU signed.- GHS supported with health facilities and personnel.- CRS trained Traditional Birth Attendants (TBAs) and community volunteers in social mobilization skills, provided logistics/incentives to attract pregnant women to deliver in health centres.- Program officers of CRS and focal persons of GHS shared equally in program management and regularly exchanged project progress information.- GHS held review meetings at sub-district, district and regional; quarterly, half yearly and annual basis, to evaluate progress with CRS/stakeholders.- CRS maintained monitoring and evaluation systems e.g. conduct of baseline studies; mid- term and end-of-project evaluations.- Quarterly and annual reports generated and shared with GHS/ donors as a requirement for continued support.- GHS required to keep records of CRS support (material and cash) and to render accounts periodically.</td><td rowspan="3">Improvement in maternal and child health indicators-e.g. antenatal registration (25 %); antenatal clinic attendance (22 %); exclusive breastfeeding (25 %); institutional deliveries (55 %); [35] and increased drug and immunization uptake.</td><td rowspan="3">- Occasional tendency for some GHS staff to provide somewhat unreliable data not useful for effective programming;- Occasional non-disclosure of full budget lines by GHS- Lack of synchronization of each other’s timetables;- CRS’ eagerness about timelines to demonstrate program performance to donors.</td></tr><tr><td>Driver of Collaboration</td><td>High under-five and maternal mortality recognized by GHS;- Need to attract pregnant women to deliver in government health centres rather than with TBAs.</td></tr><tr><td>Time Frame</td><td>2009–2011</td></tr></table> |
1b93c6691d2dc872c6549567ed53512d7ebd557d35c7c646444cac75970c6a04.png | simple | <table><tr><td></td><td>Nuevo Laredo</td><td>Matamoros</td><td>Veracruz</td></tr><tr><td>Iowa</td><td>Train: 1686 km</td><td>Train: 1800 km</td><td>Train: 220 kmWater: 2300 km</td></tr><tr><td>Ilinois</td><td>Train: 1637 km</td><td>Train: 1700 km</td><td>Train: 405 kmWater: 2300 km</td></tr><tr><td>Indiana</td><td>Train: 1833 km</td><td>Train: 1885 km</td><td>Train: 677 kmWater: 2300 km</td></tr><tr><td>Total </td><td>1718 km + 650 km to the middle of the country</td><td>1795 km + 650 km to the middle of the country</td><td>434 km, train + 650 km to the middle of the country, Water: 2300 km </td></tr></table> |
6311c9d7da173e4a8ddf6cc2b1f1dfbd304672c07e4ad3c2fb3442f645615a79.png | complex | <table><tr><td>Model</td><td>LnL</td><td>AIC</td><td>AIC<sub>c</sub></td><td>ΔAIC<sub>c</sub></td><td>AIC<sub>c</sub>Wt</td></tr><tr><td colspan="6">Legacy calibrated phylogeny</td></tr><tr><td> Brownian motion single rate</td><td>123.77</td><td>−229.54</td><td>−203.82</td><td>221</td><td>0.00</td></tr><tr><td> Brownian motion multiple rate</td><td>130.51</td><td>−219.03</td><td>−403.83</td><td>20.99</td><td>0.00</td></tr><tr><td> Ornstein-Uhlbeck single rate</td><td>134.9</td><td>−239.91</td><td>240.09</td><td>664.91</td><td>0.00</td></tr><tr><td> Ornstein-Uhlbeck multiple rate</td><td>141.01</td><td>−240.02</td><td>−424.82</td><td>0.00</td><td>0.99</td></tr><tr><td> Ecological release</td><td>125.02</td><td>−220.04</td><td>259.96</td><td>684.78</td><td>0.00</td></tr><tr><td> Release and radiate</td><td>135.67</td><td>−229.34</td><td>−414.14</td><td>10.68</td><td>0.00</td></tr><tr><td> Ecological constraint</td><td>119.64</td><td>−209.28</td><td>270.72</td><td>695.54</td><td>0.00</td></tr><tr><td> Radiation & ecological constraint</td><td>126.43</td><td>−210.86</td><td>−395.66</td><td>30.16</td><td>0.00</td></tr><tr><td> Brownian motion/early burst</td><td>122.50</td><td>−225.01</td><td>−188.34</td><td>236.48</td><td>0.00</td></tr><tr><td> Early burst/Brownian motion</td><td>53.24</td><td>−86.49</td><td>−49.83</td><td>374.99</td><td>0.00</td></tr><tr><td colspan="6">Isthmus calibrated phylogeny</td></tr><tr><td> Brownian motion single rate</td><td>123.94</td><td>−229.89</td><td>−204.17</td><td>223.12</td><td>0.00</td></tr><tr><td> Brownian motion multiple rate</td><td>131.21</td><td>−220.42</td><td>−405.22</td><td>22.07</td><td>0.00</td></tr><tr><td> Ornstein-Uhlbeck single rate</td><td>135.1</td><td>−240.19</td><td>239.81</td><td>667.10</td><td>0.00</td></tr><tr><td> Ornstein-Uhlbeck multiple rate</td><td>142.24</td><td>−242.49</td><td>−427.29</td><td>0.00</td><td>0.99</td></tr><tr><td> Ecological release</td><td>129.60</td><td>−229.20</td><td>250.80</td><td>678.09</td><td>0.00</td></tr><tr><td> Release and radiate</td><td>135.48</td><td>−228.97</td><td>−413.77</td><td>13.52</td><td>0.00</td></tr><tr><td> Ecological constraint</td><td>123.47</td><td>−216.94</td><td>263.05</td><td>690.34</td><td>0.00</td></tr><tr><td> Radiation & ecological constraint</td><td>125.51</td><td>−209.02</td><td>−393.82</td><td>33.47</td><td>0.00</td></tr><tr><td> Brownian motion/early burst</td><td>121.06</td><td>−222.13</td><td>−185.47</td><td>241.82</td><td>0.00</td></tr><tr><td> Early burst/Brownian motion</td><td>121.78</td><td>−223.55</td><td>−186.89</td><td>240.40</td><td>0.00</td></tr></table> |
f40e83e0dcace92dcd03fd217400ba1fdbde02a11ddd3890f3b64b4d91d9c3a8.png | simple | <table><tr><td>Gene</td><td>Target sequence</td><td>ShRNA sequences</td></tr><tr><td>CXCR4-1</td><td>TCCTGGCCTTCATCAGTCT (6)</td><td>5′-GAT CCT CCT GGC CTT CAT CAG TCT TTC AAG AGA AGA CTG ATG AAG GCC AGG ATT TTT GGA AGC TAG GA-3′</td></tr><tr><td>CXCR4-2</td><td>TGCCCACCATCTACTCCAT (7)</td><td>5′-GAT CCT GCC CAC CAT CTA CTC CAT TTC AAG AGA ATG GAG TAG ATG GTG GGC ATT TTT GGA AGC TAG CA-3′</td></tr><tr><td>Negative control</td><td>AATCGCATAGCGTATGCCGTT (8)</td><td>5′-GAT CCA ATC GCA TAG CGT ATG CCG TTT TCA AGA GAA ACG GCA TAC GCT ATG CGA TTT TTT TGG AAG CTA GCA-3′</td></tr></table> |
bad8f44f6ce8797e827597f4da3acbe94bf867af4a45cf40b5f22cb6594c0047.png | simple | <table><tr><td></td><td>human</td><td>mouse</td><td>rat</td><td></td></tr><tr><td>miRanda</td><td>34 838 559</td><td>16 164 311</td><td>1 372 897</td><td></td></tr><tr><td>Pita</td><td>773 112</td><td>313 113</td><td>52 281</td><td></td></tr><tr><td>RNAHybrid</td><td>36 832 689</td><td>10 390 354</td><td>536 248</td><td></td></tr><tr><td>microtar</td><td>6 049 837</td><td>1 750 058</td><td>3 348 100</td><td></td></tr><tr><td>Targetscan</td><td>7 270 936</td><td>5 186 036</td><td>417 501</td><td></td></tr><tr><td>TarBase</td><td>36 853</td><td>20 513</td><td>7</td><td></td></tr><tr><td>miRTarbase</td><td>39 118</td><td>9 314</td><td>307</td><td></td></tr><tr><td>miRecords</td><td>1 198</td><td>227</td><td>—</td><td></td></tr><tr><td>OncomirDB</td><td>2 368</td><td>1 917</td><td>—</td><td></td></tr><tr><td>miRGate</td><td>85 844 670</td><td>33 835 843</td><td>5 727 341</td><td>125 407 854</td></tr></table> |
6e498ff31a4b4346f99e3bcbcfc30efc83f6f4516541432a6b17c7955a6dbde1.png | complex | <table><tr><td>Background characteristics</td><td>Number (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>86 (7.6)</td></tr><tr><td> Female</td><td>975 (86.3)</td></tr><tr><td> Missing</td><td>69 (6.1)</td></tr><tr><td>Age [mean, (SD)] years</td><td>28.8 (SD = 7.5)</td></tr><tr><td colspan="2">Current marital status</td></tr><tr><td> Never married</td><td>51 (4.6)</td></tr><tr><td> Married (monogamous)</td><td>827 (73.9)</td></tr><tr><td> Married (polygamous)</td><td>139 (12.4)</td></tr><tr><td> Other<sup>a</sup></td><td>102 (9.1)</td></tr><tr><td colspan="2">Education status</td></tr><tr><td> Never in school</td><td>166 (14.7)</td></tr><tr><td> Some primary</td><td>803 (71.1)</td></tr><tr><td> Above primary</td><td>151 (13.3)</td></tr><tr><td> Missing</td><td>10 (0.9)</td></tr><tr><td colspan="2">Employment status</td></tr><tr><td> Salaried</td><td>778 (68.8)</td></tr><tr><td> Unemployed</td><td>213 (18.9)</td></tr><tr><td> Subsistence farmer</td><td>70 (6.2)</td></tr><tr><td> Self-employed/wage earners</td><td>58 (5.1)</td></tr><tr><td> Missing</td><td>11 (1.0)</td></tr><tr><td colspan="2">Relationship to the child</td></tr><tr><td> Parent</td><td>1043 (92.3)</td></tr><tr><td> Kin or other</td><td>47 (4.2)</td></tr><tr><td> Missing</td><td>40 (3.5)</td></tr></table> |
1018e3b7b65c944ea6129d46b377fc10e3f14db265ed8baf9d775e73b8187a10.png | simple | <table><tr><td>VP1 NTa position</td><td>NTs in Sabin 2 and cVDPV2 sequences</td><td>iVDPV2 sequences</td><td># sequences (iVDPV2) that exhibit variations</td></tr><tr><td>32</td><td>A</td><td>A or C</td><td>7</td></tr><tr><td>116</td><td>A</td><td>A or G</td><td>1</td></tr><tr><td>208</td><td>C</td><td>A or C</td><td>1</td></tr><tr><td>218</td><td>C</td><td>C or T</td><td>1</td></tr><tr><td>223</td><td>T</td><td>A or T</td><td>12</td></tr><tr><td>302</td><td>C</td><td>A or C</td><td>1</td></tr><tr><td>307</td><td>A</td><td>Deletionb</td><td>1</td></tr><tr><td>358</td><td>C</td><td>C or T</td><td>1</td></tr><tr><td>433</td><td>G</td><td>G or T</td><td>12</td></tr><tr><td>496</td><td>A</td><td>A or G</td><td>1</td></tr><tr><td>502</td><td>G</td><td>A or G</td><td>1</td></tr><tr><td>506</td><td>A</td><td>A or C</td><td>1</td></tr><tr><td>604</td><td>G</td><td>A or G</td><td>1</td></tr><tr><td>740</td><td>A</td><td>A or G</td><td>1</td></tr><tr><td>761</td><td>C</td><td>C or T</td><td>1</td></tr><tr><td>781</td><td>A</td><td>A or C or T</td><td>11C; 1 T</td></tr></table> |
6da5f92c709fbacfce52a127422a99af2f43ef3a25b2ca5e747795c9b466a3fe.png | simple | <table><tr><td>Description</td><td>E7 Clusters*</td><td>E14 Clusters*</td></tr><tr><td>Affected only by serum</td><td>13, 39</td><td>13, 39</td></tr><tr><td>Affected only by rcSF3</td><td>None</td><td>None</td></tr><tr><td>Serum and rcSF3 oppose one another</td><td>7, 14, 18, 34, 35, 38</td><td>14, 18, 34, 38</td></tr><tr><td>Serum and rcSF3 reinforce one another</td><td>0, 8, 49</td><td>0, 8, 10, 49</td></tr><tr><td>Serum and rcSF3 modulate one another</td><td>2, 5, 42</td><td>2, 5, 10, 47</td></tr><tr><td>Serum and rcSF3 substitute for one another</td><td>None</td><td>12</td></tr><tr><td>Gene expression increases with increasing TER</td><td>42</td><td>None</td></tr><tr><td>Gene expression decreases with increasing TER</td><td>None</td><td>None</td></tr></table> |
f9df9a9579fb17a604ff8cb12d2c4fb1353c3571734b66ab938f216d7d79ef05.png | complex | <table><tr><td></td><td colspan="4">L/min</td></tr><tr><td></td><td>2.5</td><td>5</td><td>7.5</td><td>10</td></tr><tr><td>Aysis</td><td>15.41</td><td>4.25</td><td>2.14</td><td>2.15</td></tr><tr><td>FLOW-i</td><td>10.73</td><td>4.45</td><td>2.49</td><td>2.48</td></tr></table> |
410e8c2cb0ab092931f9c8f25673ce1373f2b3b55fdd0e5489639549b670ef7f.png | simple | <table><tr><td> </td><td>Activity monitor group (<i>n</i> = 14)</td><td>Pedometer group (<i>n</i> = 14)</td><td><i>p</i> value</td></tr><tr><td>Age (years)</td><td>65.8 ± 6.7</td><td>62.4 ± 9.9</td><td>0.58</td></tr><tr><td>Male</td><td>78.6%</td><td>71.4%</td><td>0.66</td></tr><tr><td>Height (m)</td><td>1.61 ± 0.08</td><td>1.63 ± 0.09</td><td>0.46</td></tr><tr><td>Weight (kg)</td><td>62.4 ± 12.7</td><td>68.3 ± 9.5</td><td>0.08</td></tr><tr><td>BMI</td><td>24.1 ± 4.0</td><td>25.9 ± 4.3</td><td>0.24</td></tr><tr><td>HbA1c (%)</td><td>6.6 ± 0.6</td><td>6.4 ± 0.9</td><td>0.27</td></tr><tr><td>Systolic BP (mmHg)</td><td>121.1 ± 10.8</td><td>121.6 ± 6.8</td><td>0.89</td></tr><tr><td>Diastolic BP (mmHg)</td><td>67.8 ± 8.1</td><td>73.5 ± 9.0</td><td>0.09</td></tr><tr><td>UA (mg/dL)</td><td>5.5 ± 1.6</td><td>5.6 ± 1.6</td><td>0.80</td></tr><tr><td>HDL cholesterol (mg/dL)</td><td>66.6 ± 18.7</td><td>60.3 ± 11.6</td><td>0.72</td></tr><tr><td>LDL cholesterol (mg/dL)</td><td>111.4 ± 34.9</td><td>103 ± 10.8</td><td>0.09</td></tr><tr><td>Triglycerides (mg/dL)</td><td>107.6 ± 59.7</td><td>127.1 ± 90.8</td><td>0.68</td></tr></table> |
b5fbfae31586da4b2308e5d4cf3bedc2602e564ff47ed99fa1e062b280cd4f4b.png | complex | <table><tr><td>Version</td><td></td><td>Parameter</td><td>Separation index</td><td>Reliability</td><td>Average infit mean square</td><td>Average outfit mean square</td></tr><tr><td rowspan="4">Malay</td><td rowspan="2">9-items</td><td>Person ability</td><td>2.84</td><td>0.89</td><td>1.00</td><td>1.01</td></tr><tr><td>Item difficulty</td><td>4.81</td><td>0.96</td><td>1.00</td><td>1.00</td></tr><tr><td rowspan="2">7-items<sup>a</sup></td><td>Person ability</td><td>2.59</td><td>0.87</td><td>1.00</td><td>0.99</td></tr><tr><td>Item difficulty</td><td>4.97</td><td>0.96</td><td>1.00</td><td>0.98</td></tr><tr><td rowspan="4">Chinese</td><td rowspan="2">9-items</td><td>Person ability</td><td>2.59</td><td>0.87</td><td>1.00</td><td>1.01</td></tr><tr><td>Item difficulty</td><td>6.96</td><td>0.98</td><td>1.00</td><td>1.02</td></tr><tr><td rowspan="2">7-items<sup>a</sup></td><td>Person ability</td><td>2.30</td><td>0.84</td><td>1.01</td><td>0.98</td></tr><tr><td>Item difficulty</td><td>5.28</td><td>0.97</td><td>1.00</td><td>0.98</td></tr></table> |
e8e5d0ba6fd11f996676962589e7eb0e4957927fed337bacc985b6a5085ca2d2.png | simple | <table><tr><td>Target</td><td>Forward primer</td><td>Reverse primer</td><td>Product length [bp]</td><td>Reference</td></tr><tr><td><i>HPRT</i></td><td>GAGAGCGTTGGGCTTACCTC</td><td>ATCGCTAATCACGACGCTGG</td><td>136</td><td>Rohm et al., 2015</td></tr><tr><td><i>PPARG</i></td><td>GTGCCAGTTTCGATCCGTAGA</td><td>GGCCAGCATCGTGTAGATGA</td><td>142</td><td>Rohm et al., 2015</td></tr><tr><td><i>FAS</i></td><td>CACAGATGATGACAGGAGATGG</td><td>TCGGAGTGAGGCTGGGTTGAT</td><td>205</td><td>Hewitt et al., 2004</td></tr><tr><td><i>LRP2</i></td><td>TGTACCAGAAAATGTGGAAAACC</td><td>GTGTCTTCTGTGGCAGTGTAGC</td><td>288</td><td>Lyons et al., 2003</td></tr><tr><td><i>IGF1R</i></td><td>GGAGTGTCCCTCAGGCTTCA</td><td>CATCGCCGCAGACTTTGG</td><td>89</td><td>Nef et al., 2003</td></tr></table> |
c2057b7a3abad7688868c4d5eb53996b7598c730ecad675f1a6243e10ef6a9fe.png | complex | <table><tr><td rowspan="2">Study</td><td colspan="2">No. randomized</td><td rowspan="2">Characteristics of patients</td><td colspan="2">BMI (SD)</td><td colspan="2">Mean APACHE II score (SD)</td></tr><tr><td>LE</td><td>HE</td><td>LE</td><td>HE</td><td>LE</td><td>HE</td></tr><tr><td rowspan="2">Arabi <i>et al</i>. [21]</td><td rowspan="2">120</td><td rowspan="2">120</td><td>>18 years old</td><td rowspan="2">28.5 (7.4)</td><td rowspan="2">28.5 (8.4)</td><td rowspan="2">25.2 (7.5)</td><td rowspan="2">25.3 (8.2)</td></tr><tr><td>ICU >48 hours</td></tr><tr><td rowspan="3">Braunschweig <i>et al</i>. [22]</td><td rowspan="3">38</td><td rowspan="3">40</td><td>>18 years old</td><td rowspan="3">30.1 (8.9)</td><td rowspan="3">29.8 (9.3)</td><td rowspan="3">27.7 (7.9)</td><td rowspan="3">23.4 (9.3)</td></tr><tr><td>Medical or surgical ICU</td></tr><tr><td>ALI <24 hours</td></tr><tr><td rowspan="3">Charles <i>et al</i>. [23]</td><td rowspan="3">41</td><td rowspan="3">42</td><td>>18 years old</td><td rowspan="3">32.9 (2.0)</td><td rowspan="3">28.1 (0.9)</td><td rowspan="3">16.6 (0.9)</td><td rowspan="3">17.3 (0.8)</td></tr><tr><td>Artificial nutrition >48 hours</td></tr><tr><td>ICU >48 hours</td></tr><tr><td rowspan="3">Desachy <i>et al</i>. [24]</td><td rowspan="3">50</td><td rowspan="3">50</td><td>>18 years old</td><td rowspan="3">27 (5)</td><td rowspan="3">25 (3)</td><td rowspan="3">40 (11)<sup>1</sup></td><td rowspan="3">42 (17)<sup>1</sup></td></tr><tr><td>Medical or surgical ICU</td></tr><tr><td>Mechanical ventilation >72 hours</td></tr><tr><td rowspan="3">Peake <i>et al</i>. [25]</td><td rowspan="3">55</td><td rowspan="3">57</td><td>≥18 years old</td><td rowspan="3">26.2 (6.4)</td><td rowspan="3">27.8 (7.9)</td><td rowspan="3">22 (8.9)</td><td rowspan="3">23 (9.1)</td></tr><tr><td>Enteral nutrition ≥2 days</td></tr><tr><td>Mechanical ventilation</td></tr><tr><td rowspan="2">Rice <i>et al</i>. [26]</td><td rowspan="2">98</td><td rowspan="2">102</td><td>ICU admission</td><td rowspan="2">29.2 (10.2)</td><td rowspan="2">28.2 (9.4)</td><td rowspan="2">26.9 (8.1)</td><td rowspan="2">26.9 (6.6)</td></tr><tr><td>Mechanical ventilation >72 hours</td></tr><tr><td rowspan="3">Rice <i>et al</i>. [27]</td><td rowspan="3">508</td><td rowspan="3">492</td><td>ICU admission</td><td rowspan="3">29.9 (7.8)</td><td rowspan="3">30.4 (8.2)</td><td rowspan="3">92 (28)<sup>2</sup></td><td rowspan="3">90 (27)<sup>2</sup></td></tr><tr><td>ALI <48 hours</td></tr><tr><td>Mechanical ventilation >72 hours</td></tr><tr><td rowspan="2">Taylor <i>et al</i>. [28]</td><td rowspan="2">41</td><td rowspan="2">41</td><td>Head injury necessitating mechanical ventilation</td><td rowspan="2">N/A</td><td rowspan="2">N/A</td><td rowspan="2">14<sup>3</sup></td><td rowspan="2">14<sup>3</sup></td></tr><tr><td>Glasgow Coma Scale >3</td></tr></table> |
73f2831108a8a9b731f9e4a9918253124721e16acfd870449eb6808a608f6607.png | simple | <table><tr><td>Learning rate <i>η</i></td><td>The number of hidden neurons</td><td>10</td><td>20</td><td>30</td><td>40</td><td>50</td><td>60</td><td>70</td><td>80</td><td>90</td><td>100</td></tr><tr><td>0.0005</td><td>Training time (seconds)</td><td>4092.19</td><td>4213.25</td><td>4276.55</td><td>4424.77</td><td>4455.69</td><td>4589.70</td><td>4553.02</td><td>4640.63</td><td>4745.16</td><td>4884.30</td></tr><tr><td></td><td>Testing accuracy (%)</td><td>94.77</td><td>94.00</td><td>94.16</td><td>95.32</td><td>94.74</td><td>92.62</td><td>92.52</td><td>90.28</td><td>88.77</td><td>89.91</td></tr><tr><td>0.001</td><td>Training time (seconds)</td><td>4058.33</td><td>4157.41</td><td>4218.09</td><td>4354.41</td><td>4408.23</td><td>4500.06</td><td>5.75*</td><td>1532.38*</td><td>2.38*</td><td>32.61*</td></tr><tr><td></td><td>Testing accuracy (%)</td><td>95.02</td><td>94.45</td><td>95.83</td><td>95.51</td><td>93.56</td><td>91.30</td><td>78.17</td><td>78.17</td><td>78.17</td><td>78.17</td></tr><tr><td>0.002</td><td>Training time (seconds)</td><td>4054.50</td><td>4212.85</td><td>4213.71</td><td>4385.40</td><td>1.11*</td><td>1.12*</td><td>1.12*</td><td>3.44*</td><td>1.17*</td><td>144.12*</td></tr><tr><td></td><td>Testing accuracy (%)</td><td>96.42</td><td>95.72</td><td>89.37</td><td>86.15</td><td>78.17</td><td>78.17</td><td>78.17</td><td>78.17</td><td>78.17</td><td>78.17</td></tr></table> |
da7eecbc6a178e55758c253aa42fb1302aa4a9073c74e6339f97c9241fe72bb3.png | complex | <table><tr><td>Gene name</td><td colspan="2">Primer sequence (5' to 3')</td><td>Position in ORF</td></tr><tr><td>APN1</td><td>3'Race</td><td>TGCGCTTCGAAGATTGGCTCACGATA</td><td>2018–2044</td></tr><tr><td></td><td>5'Race</td><td>CTTCGATGAATGCCGAGACGCTGGAC</td><td>2122–2097</td></tr><tr><td>APN2</td><td>3'Race</td><td>CTTTGCTGCTGGTGCTATGGAGAACTGG</td><td>906–932</td></tr><tr><td></td><td>5'Race</td><td>ACAGGGCTGACTTCATTTCCGAACCATT</td><td>1067–1040</td></tr><tr><td>APN3</td><td>3'Race</td><td>ATGCGTGAYGAYATGTACGGTAT</td><td>496–518</td></tr><tr><td></td><td>5'Race</td><td>GCCAGGAGATAAGTTGACATTTTTGGGG</td><td>779–752</td></tr><tr><td>APN4</td><td>3'Race</td><td>TGGCTTTCCATGTGAGCGATTTTGTGC</td><td>728–754</td></tr><tr><td></td><td>5'Race</td><td>CACACCGATTTCTGCAGCATACGAGTGC</td><td>849–822</td></tr></table> |
edeab8acf755d3085b322ab112852e7266e3b5874dd3fdd053938484a3f1ffe3.png | simple | <table><tr><td>Symbol</td><td>Definition</td><td>|Fold Change|(TM/TM-MSC)</td><td><i>P</i><sub>adj</sub></td></tr><tr><td><i>MYOC</i></td><td>Myocilin, trabecular meshwork inducible glucocorticoid response</td><td>1374</td><td>6.97E-04</td></tr><tr><td><i>ANGPTL7</i></td><td>Angiopoietin-like 7</td><td>1189</td><td>1.48E-03</td></tr><tr><td><i>PCP4</i></td><td>Purkinje cell protein 4</td><td>656</td><td>2.33E-03</td></tr><tr><td><i>KRT13</i></td><td>Keratin 13</td><td>459</td><td>1.08E-03</td></tr><tr><td><i>SERPINA3</i></td><td>Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3</td><td>447</td><td>3.75E-03</td></tr><tr><td><i>MYH11</i></td><td>Myosin, heavy chain 11, smooth muscle</td><td>429</td><td>1.00E-02</td></tr><tr><td><i>CDH23</i></td><td>Cadherin-like 23</td><td>420</td><td>6.97E-04</td></tr><tr><td><i>HLA-DRA</i></td><td>Major histocompatibility complex, class II, DR alpha</td><td>354</td><td>9.27E-04</td></tr><tr><td><i>PTGDS</i></td><td>Prostaglandin D2 synthase 21 kDa (Brain)</td><td>300</td><td>2.05E-02</td></tr><tr><td><i>FAM107A</i></td><td>Family with sequence similarity 107, member A</td><td>275</td><td>6.97E-04</td></tr><tr><td><i>HBB</i></td><td>Hemoglobin, beta</td><td>264</td><td>4.13E-03</td></tr><tr><td><i>C2orf40</i></td><td>Chromosome 2 open reading frame 40</td><td>239</td><td>8.31E-04</td></tr><tr><td><i>FCGBP</i></td><td>Fc fragment of IgG binding protein</td><td>231</td><td>9.27E-04</td></tr><tr><td><i>APOD</i></td><td>Apolipoprotein D</td><td>230</td><td>2.40E-02</td></tr><tr><td><i>CXADR</i></td><td>Coxsackie virus and adenovirus receptor</td><td>218</td><td>7.76E-04</td></tr><tr><td><i>TACSTD2</i></td><td>Tumor-associated calcium signal transducer 2</td><td>215</td><td>9.45E-04</td></tr><tr><td><i>H19</i></td><td>H19, imprinted maternally expressed transcript (non-protein coding)</td><td>210</td><td>1.38E-03</td></tr><tr><td><i>KRT5</i></td><td>Keratin 5</td><td>209</td><td>7.76E-04</td></tr><tr><td><i>CCL3L3</i></td><td>Chemokine (C-C motif) ligand 3-like 3</td><td>209</td><td>1.27E-03</td></tr><tr><td><i>VCAM1</i></td><td>Vascular cell adhesion molecule 1</td><td>199</td><td>2.49E-03</td></tr></table> |
fe94add4d6f335450343dc48a475cf820da7d7aee8bc4067c8bce7f2ce46f634.png | simple | <table><tr><td>Session Topic</td><td>Protective Factor Targeted</td></tr><tr><td>Introduction and Program Overview<i>READY </i>resilience model, protective factors, warning signs of low resilience.</td><td></td></tr><tr><td>Activity Promotion (group 2 only)Activity benefits, national activity guidelines, step counting & pedometers, identifying preferences, goal setting, barriers & problem solving.</td><td>Physical activity</td></tr><tr><td>MindfulnessMindfulness vs mindlessness, mindfulness strategies.</td><td>Cognitive flexibilityPositive emotions</td></tr><tr><td>Defusion 1Thought fusion, identifying unhelpful thoughts, defusion strategies.</td><td>Cognitive flexibility</td></tr><tr><td>Defusion 2Observer self, defusion strategies.</td><td>Cognitive flexibility</td></tr><tr><td>AcceptanceAbout emotions, responding to emotions, about acceptance, acceptance strategies.</td><td>Positive emotions</td></tr><tr><td>Mid Program ReviewResilient and non resilient characteristics, activating and trouble shooting coping strategies.</td><td>Active coping</td></tr><tr><td>Life Values and Meaningful ActionAbout values, value identification, meaningful action.</td><td>Life meaning</td></tr><tr><td>Social ConnectednessTypes of support, support responses, active and reflective listening, barriers to social connectedness.</td><td>Social support</td></tr><tr><td>Relaxation and Pleasant ActivitiesActive relaxation exercises, progressive muscle relaxation exercises, pleasurable activities.</td><td>Positive emotions</td></tr><tr><td>Review and Planning for the FutureResilient and non resilient characteristics, activating and trouble shooting coping strategies.</td><td>Active coping</td></tr></table> |
e8b9692fb215cdf379ea1caf3aa83ff06eaf7dc47234f5cae3cc6cbb22aad7bd.png | complex | <table><tr><td></td><td></td><td colspan="6">Three-dimensional scapular attitudes (in degrees)</td></tr><tr><td></td><td></td><td colspan="2">Healthy subjects</td><td colspan="4">SIS subjects</td></tr><tr><td></td><td></td><td></td><td></td><td>Impaired shoulder</td><td></td><td>Non-impaired shoulder</td><td></td></tr><tr><td>Arm Positions</td><td>Scapular Rotations</td><td>n = 30 shoulders</td><td></td><td>n = 8 shoulders</td><td></td><td>n = 8 shoulders</td><td></td></tr><tr><td></td><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Rest</td><td>A(-) P(+) T</td><td>-9.2</td><td>4.3</td><td>-7.4</td><td>3.7</td><td>-6.6</td><td>4.2</td></tr><tr><td></td><td>L(-) M(+) R</td><td>-1.1</td><td>4.7</td><td>-7.6</td><td>3.7</td><td>-5.3</td><td>4.0</td></tr><tr><td></td><td>PRO(+) RET(-)</td><td>-31.8</td><td>5.6</td><td>-33.3</td><td>6.8</td><td>-32.1</td><td>5.5</td></tr><tr><td>Flexion 70°</td><td>A(-) P(+) T</td><td>-3.8</td><td>4.5</td><td>-3.2</td><td>3.9</td><td>-1.9</td><td>5.2</td></tr><tr><td></td><td>L(-) M(+) R</td><td>-9.3</td><td>3.7</td><td>-14.5</td><td>4.5</td><td>-12.4</td><td>4.2</td></tr><tr><td></td><td>PRO(+) RET(-)</td><td>-39.8</td><td>7.5</td><td>-40.7</td><td>8.2</td><td>-39.5</td><td>6.7</td></tr><tr><td>Abduction 90°</td><td>A(-) P(+) T</td><td>-1.6</td><td>5.6</td><td>-1.7</td><td>5.2</td><td>-1.4</td><td>7.1</td></tr><tr><td></td><td>L(-) M(+) R</td><td>-27.5</td><td>4.2</td><td>-30.4</td><td>4.7</td><td>-31.6</td><td>9.0</td></tr><tr><td></td><td>PRO(+) RET(-)</td><td>-19.1</td><td>6.1</td><td>-18.6</td><td>8.7</td><td>-20.1</td><td>6.6</td></tr></table> |
6d031afddcb45c8a2d10968144e8e8d354f97cbc75adc57efc56b0bee4044802.png | simple | <table><tr><td>SF-36 Domains</td><td>Total Patients (n=308)</td><td>Thalassemia Major (n=209)</td><td>Thalassemia Intermedia (n=99)</td><td>Healthy Individuals† (n=4804)</td></tr><tr><td>Physical Functioning*</td><td>67.95 (22.68)</td><td>72.11 (21.19)</td><td>59.19 (23.34)</td><td>85.2 (20.8)</td></tr><tr><td>Role Limitation-Physical</td><td>53.24 (18.58)</td><td>54.31 (17.88)</td><td>50.96 (19.89)</td><td>70.0 (38.0)</td></tr><tr><td>General Health</td><td>53.05 (16.96)</td><td>52.69 (17.42)</td><td>53.84 (15.99)</td><td>67.5 (20.4)</td></tr><tr><td>Vitality</td><td>55.02 (14.93)</td><td>54.31 (15.05)</td><td>56.57 (14.61)</td><td>65.8 (17.3)</td></tr><tr><td>Social Functioning</td><td>60.11 (20.89)</td><td>60.11 (20.84)</td><td>60.10 (21.10)</td><td>76.0 (24.4)</td></tr><tr><td>Role Limitation-Emotional*</td><td>55.13 (21.09)</td><td>57.89 (19.64)</td><td>49.32 (22.91)</td><td>65.6 (41.1)</td></tr><tr><td>Mental Health</td><td>56.91 (16.40)</td><td>56.22 (15.54)</td><td>58.40 (18.11)</td><td>67.0 (18.0)</td></tr><tr><td>Bodily Pain*</td><td>55.47 (20.96)</td><td>53.40 (20.48)</td><td>59.88 (21.38)</td><td>79.4 (25.1)</td></tr></table> |
e5b15400e8f05b2d648ca9074e4df4e89c9dea6709a7c5a50a6d5bc849df6b3e.png | complex | <table><tr><td colspan="2">Characteristic</td><td>Control Group</td><td>OC Group</td><td>T-Test</td></tr><tr><td>Age</td><td></td><td>20.3 (2.56)</td><td>20.5 (1.79)</td><td>n.s.</td></tr><tr><td>Education (yrs)</td><td></td><td>14.8 (1.68)</td><td>15.4 (1.93)</td><td>n.s.</td></tr><tr><td>BMI</td><td></td><td>23.3 (3.85)</td><td>24.3 (4.50)</td><td>n.s.</td></tr><tr><td>Cycle length</td><td></td><td>30.5 (4.12)</td><td>27.6 (1.29)</td><td>t = 2.99, p < 0.01</td></tr><tr><td>Test Day</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2"> Follicular</td><td>5.6 (2.24)</td><td>6.0 (1.97)</td><td>n.s.</td></tr><tr><td colspan="2"> Mid-Cycle</td><td>14.5 (2.21)</td><td>14.0 (1.17)</td><td>n.s.</td></tr><tr><td colspan="2"> Luteal</td><td>22.8 (3.00)</td><td>22.2 (1.44)</td><td>n.s.</td></tr><tr><td>Race/Ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2"> Caucasian/NHW</td><td>8 (40%)</td><td>11 (55%)</td><td></td></tr><tr><td colspan="2"> African American/Black</td><td>1 (5%)</td><td>1 (5%)</td><td></td></tr><tr><td colspan="2"> Hispanic/Latino</td><td>5 (25%)</td><td>5 (25%)</td><td></td></tr><tr><td colspan="2"> Asian/Pacific Islander</td><td>6 (30%)</td><td>3 (15%)</td><td></td></tr></table> |
4eff32018717d63d419af6920546a706862c94ad8b42238e5f0c757dfadfe969.png | simple | <table><tr><td></td><td></td><td>Median score</td><td>U</td><td>Z</td><td><i>p</i></td><td>r</td></tr><tr><td>AN-R</td><td>ASRSTS</td><td>7</td><td></td><td></td><td></td><td></td></tr><tr><td>AN-BP (vs. AN-R)</td><td>ASRSTS</td><td>11</td><td>910</td><td>−2.34</td><td>0.019</td><td>0.23</td></tr><tr><td>BN (vs. AN-R)</td><td>ASRSTS</td><td>12</td><td>8942</td><td>−4.98</td><td>0.000*</td><td>0.23</td></tr><tr><td>EDNOS-BP (vs. AN-R)</td><td>ASRSTS</td><td>10</td><td>7922</td><td>−3.80</td><td>0.000*</td><td>0.19</td></tr><tr><td>BED (vs. AN-R)</td><td>ASRSTS</td><td>10</td><td>2187</td><td>−3.17</td><td>0.002*</td><td>0.25</td></tr><tr><td>AN-R</td><td>ITS</td><td>5</td><td></td><td></td><td></td><td></td></tr><tr><td>AN-BP (vs. AN-R)</td><td>ITS</td><td>7</td><td>855</td><td>−2.72</td><td>0.007*</td><td>0.26</td></tr><tr><td>BN (vs. AN-R)</td><td>ITS</td><td>8</td><td>8480</td><td>−5.41</td><td>0.000*</td><td>0.24</td></tr><tr><td>EDNOS-BP (vs. AN-R)</td><td>ITS</td><td>6</td><td>7982</td><td>−3.73</td><td>0.000*</td><td>0.19</td></tr><tr><td>BED (vs. AN-R)</td><td>ITS</td><td>7</td><td>1930</td><td>−4.07</td><td>0.000*</td><td>0.32</td></tr><tr><td>AN-R</td><td>HTS</td><td>3</td><td></td><td></td><td></td><td></td></tr><tr><td>AN-BP (vs. AN-R)</td><td>HTS</td><td>5</td><td>1033</td><td>−1.53</td><td>0.127</td><td>0.15</td></tr><tr><td>BN (vs. AN-R)</td><td>HTS</td><td>4</td><td>11801</td><td>−2.34</td><td>0.019</td><td>0.11</td></tr><tr><td>EDNOS-BP (vs. AN-R)</td><td>HTS</td><td>4</td><td>8995</td><td>−2.57</td><td>0.010*</td><td>0.13</td></tr><tr><td>BED (vs. AN-R)</td><td>HTS</td><td>3</td><td>2959</td><td>−0.47</td><td>0.635</td><td>0.04</td></tr><tr><td>AN-R</td><td>CPRS-dep</td><td>9.5</td><td></td><td></td><td></td><td></td></tr><tr><td>AN-BP (vs. AN-R)</td><td>CPRS-dep</td><td>11.5</td><td>955</td><td>−2.03</td><td>0.042</td><td>0.06</td></tr><tr><td>BN (vs. AN-R)</td><td>CPRS-dep</td><td>11.0</td><td>11901</td><td>−2.23</td><td>0.026</td><td>0.07</td></tr><tr><td>EDNOS-BP (vs. AN-R)</td><td>CPRS-dep</td><td>10.0</td><td>9947</td><td>−1.44</td><td>0.150</td><td>0.04</td></tr><tr><td>BED (vs. AN-R)</td><td>CPRS-dep</td><td>10.0</td><td>2763</td><td>−1.16</td><td>0.248</td><td>0.04</td></tr></table> |
86584c4f9a75cc6b47ba0a57ff7c041107809ef8cdcd28f911511158c51ebebb.png | simple | <table><tr><td>No.</td><td>JAT</td><td>COP</td><td>BER</td><td>EPI</td><td>PAL</td><td>Inhibiting ratio (%)</td></tr><tr><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>90.6</td></tr><tr><td>2</td><td>1</td><td>1</td><td>1</td><td>−1</td><td>−1</td><td>70.0</td></tr><tr><td>3</td><td>1</td><td>1</td><td>−1</td><td>1</td><td>−1</td><td>50.7</td></tr><tr><td>4</td><td>1</td><td>1</td><td>−1</td><td>−1</td><td>1</td><td>44.1</td></tr><tr><td>5</td><td>1</td><td>−1</td><td>1</td><td>1</td><td>−1</td><td>66.3</td></tr><tr><td>6</td><td>1</td><td>−1</td><td>1</td><td>−1</td><td>1</td><td>72.9</td></tr><tr><td>7</td><td>1</td><td>−1</td><td>−1</td><td>1</td><td>1</td><td>30.0</td></tr><tr><td>8</td><td>1</td><td>−1</td><td>−1</td><td>−1</td><td>−1</td><td>32.5</td></tr><tr><td>9</td><td>−1</td><td>1</td><td>1</td><td>1</td><td>−1</td><td>43.0</td></tr><tr><td>10</td><td>−1</td><td>1</td><td>1</td><td>−1</td><td>1</td><td>70.4</td></tr><tr><td>11</td><td>−1</td><td>1</td><td>−1</td><td>1</td><td>1</td><td>52.3</td></tr><tr><td>12</td><td>−1</td><td>1</td><td>−1</td><td>−1</td><td>−1</td><td>30.4</td></tr><tr><td>13</td><td>−1</td><td>−1</td><td>1</td><td>1</td><td>1</td><td>61.9</td></tr><tr><td>14</td><td>−1</td><td>−1</td><td>1</td><td>−1</td><td>−1</td><td>26.3</td></tr><tr><td>15</td><td>−1</td><td>−1</td><td>−1</td><td>1</td><td>−1</td><td>37.3</td></tr><tr><td>16</td><td>−1</td><td>−1</td><td>−1</td><td>−1</td><td>1</td><td>16.2</td></tr><tr><td>17</td><td>−2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>20.9</td></tr><tr><td>18</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>40.4</td></tr><tr><td>19</td><td>0</td><td>−2</td><td>0</td><td>0</td><td>0</td><td>29.3</td></tr><tr><td>20</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td><td>71.0</td></tr><tr><td>21</td><td>0</td><td>0</td><td>−2</td><td>0</td><td>0</td><td>23.9</td></tr><tr><td>22</td><td>0</td><td>0</td><td>2</td><td>0</td><td>0</td><td>40.4</td></tr><tr><td>23</td><td>0</td><td>0</td><td>0</td><td>−2</td><td>0</td><td>17.8</td></tr><tr><td>24</td><td>0</td><td>0</td><td>0</td><td>2</td><td>0</td><td>39.2</td></tr><tr><td>25</td><td>0</td><td>0</td><td>0</td><td>0</td><td>−2</td><td>9.5</td></tr><tr><td>26</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>30.8</td></tr><tr><td>27</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>23.8</td></tr><tr><td>28</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>41.8</td></tr><tr><td>29</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>42.8</td></tr><tr><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>28.6</td></tr><tr><td>31</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>39.5</td></tr><tr><td>32</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>44.9</td></tr><tr><td>33</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>39.0</td></tr><tr><td>34</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>30.3</td></tr><tr><td>35</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>41.5</td></tr><tr><td>36</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>36.7</td></tr></table> |
abd0bfe7b01120c8606271c1207b40904265d0285873a59526ef0ec72f4b2387.png | simple | <table><tr><td>Types</td><td>Relative</td><td>Personal</td><td>DNP</td><td>All</td></tr><tr><td>EL</td><td>6</td><td>0</td><td>0</td><td>6</td></tr><tr><td>FL</td><td>5</td><td>19</td><td>6</td><td>30</td></tr><tr><td>BMB</td><td>0</td><td>8</td><td>0</td><td>8</td></tr><tr><td>Sum</td><td>11</td><td>27</td><td>6</td><td>44</td></tr></table> |
0bb56dc3624caa69a3d06c6b18006a61c27b0e2f79bb1e028c990ba4e668ab3c.png | complex | <table><tr><td>MMSE score</td><td colspan="2">SIB-L</td><td colspan="2">SIB[lang]</td></tr><tr><td></td><td>Donepezil 23 mg/day</td><td>Donepezil 10 mg/day</td><td>Donepezil 23 mg/day</td><td>Donepezil 10 mg/day</td></tr><tr><td>0 to 20<sup>b</sup></td><td>32.4 ± 8.2(<i>n </i>= 907)</td><td>32.9 ± 7.7(<i>n </i>= 462)</td><td>31.4 ± 8.3(<i>n </i>= 907)</td><td>31.9 ± 7.7(<i>n </i>= 462)</td></tr><tr><td>0 to 16</td><td>30.5 ± 8.9(<i>n </i>= 641)</td><td>31.2 ± 8.3(<i>n </i>= 331 )</td><td>29.5 ± 9.0(<i>n </i>= 641)</td><td>30.3 ± 8.4(<i>n </i>= 331)</td></tr></table> |
88fbf777a88745984bd20ad95a980f1e3d01ac04152f78d5682d661e1f364655.png | simple | <table><tr><td>First author [Reference]</td><td>Bjerregaard [[28]]</td><td>Pelletier [[29]]</td><td>Elo [[31]]</td><td>Berger [[30]]</td></tr><tr><td>Country</td><td>Denmark</td><td>Canada</td><td>Finland</td><td>Israel</td></tr><tr><td>Year</td><td>1991</td><td>1998</td><td>1979</td><td>1990</td></tr><tr><td>WB income group</td><td>High</td><td>High</td><td>High</td><td>High</td></tr><tr><td>Comparators</td><td>1. Vaccinate 15-month and 12-yr-olds</td><td>1. 1-dose child vaccination campaign</td><td>1. Vaccinate 13-yr-olds & post-partum women</td><td>1. Vaccinate children from 1 – 12 years</td></tr><tr><td> </td><td>2. Vaccinate only 15-month-olds</td><td>2. 2-dose child vaccination campaign</td><td>2. Vaccinate 13-yr-olds & 1-yr-olds</td><td>2. Vaccinate only 12-yr-olds (routine)</td></tr><tr><td> </td><td> </td><td>3. 1-dose child vaccination</td><td>3. Vaccinate only 1-yr-olds over 20 years</td><td> </td></tr><tr><td> </td><td> </td><td>4. 2-dose child vaccination</td><td> </td><td> </td></tr><tr><td>Perspective</td><td>Societal*</td><td>Societal*</td><td>Societal*</td><td>NR</td></tr><tr><td>Cost components measured</td><td>OP visits; prescriptions; hospitalizations; vaccines</td><td>OP visits; hospitalizations; laboratory tests; nursing home care; special education; indirect costs (lost productivity for illness, disability and premature death)</td><td>Fetal loss; fetal damage; annual costs; long-term costs</td><td>Vaccine; vaccination side effects; serology; OP visits; hospitalizations; hearing aids; mothers’ work loss;</td></tr><tr><td>Method of cost estimation</td><td>Micro-costing</td><td>Micro-costing; Lifetime earnings (for indirect costs)</td><td>Top-down costing based on Delphi panel</td><td>Micro-costing</td></tr><tr><td>Method of benefits estimation</td><td>Averted costs</td><td>Averted costs</td><td>Averted costs</td><td>Averted costs</td></tr><tr><td>Time period for costs and benefits</td><td>20 years</td><td>Lifetime</td><td>30 years</td><td>13 years</td></tr><tr><td>Discounting (Rate)</td><td>NR</td><td>Yes (5%)</td><td>Yes (6%)</td><td>Yes (5 and 10%)</td></tr><tr><td>Results—Benefit-cost ratio</td><td>1. 3</td><td>1. 2.6</td><td>1. 10</td><td>1. 1.1</td></tr><tr><td> </td><td>2. 2</td><td>2. 2.9</td><td>2. 3</td><td>2. 1.8</td></tr><tr><td> </td><td> </td><td>3. 3.6</td><td>3. 6</td><td> </td></tr><tr><td> </td><td> </td><td>4. 4.3</td><td> </td><td> </td></tr><tr><td>Stated conclusion</td><td>Vaccinating both age groups is preferable</td><td>The benefits of a second dose outweigh the costs</td><td>Vaccinating 13-yr-old girls and postpartum women was preferable</td><td>Vaccinating infants and adolescent girls is preferable</td></tr><tr><td>Sponsor</td><td>NR</td><td>LCDC</td><td>NR</td><td>NR</td></tr></table> |
efbfd7d42b3309d5f03f5457cd6489699cf00d17316fd4e02da46149bebe9723.png | simple | <table><tr><td>Organ</td><td>OA</td></tr><tr><td>Fifth leaf</td><td>−0.16 ± 0.07</td></tr><tr><td>Awn</td><td>0.36 ± 0.07</td></tr><tr><td>Lemma</td><td>0.42 ± 0.05</td></tr><tr><td>Palea</td><td>0.30 ± 0.04</td></tr></table> |
269d92959a2792dc8b0f02b0da5c85d4561d10f54fc421b896b3de356dda18d8.png | simple | <table><tr><td></td><td>WT 4dpp</td><td>KO 4dpp</td><td>WT 9dpp</td><td>KO 9dpp</td><td>WT adult</td><td>KO adult</td></tr><tr><td>≥2 apoptotic cells per tubule</td><td>1.4</td><td>3.4</td><td>17.6</td><td>36.4</td><td>28.0</td><td>30.5</td></tr><tr><td>Total number of tubules counted</td><td>300</td><td>300</td><td>300</td><td>300</td><td>201</td><td>201</td></tr><tr><td>Number of testes used</td><td>4</td><td>4</td><td>4</td><td>4</td><td>2</td><td>4</td></tr><tr><td><i>P</i> (Fisher's exact test</td><td>0.17</td><td></td><td>0.0006</td><td></td><td>0.8</td><td></td></tr></table> |
3f87dd463785f33a5c03c8c49ecc0ef270e24c017e9e01a1867ec7887a4cdd3e.png | simple | <table><tr><td>S. No.</td><td>Name</td><td>Description</td></tr><tr><td>1.</td><td>Circular Fingerprint</td><td>Circular fingerprint is based on CDK’s [31] circular fingerprinter and is functionally equivalent to ECFP-2 [43]</td></tr><tr><td>2.</td><td>Extended Fingerprint</td><td>Functionally equivalent to ExtendedFingerprinter of CDK [31]. This fingerprint is unique from the standard form since it accounts for ring systems. Default length size is 1024 bits.</td></tr><tr><td>3.</td><td>Substructure Fingerprint</td><td>This is a structural key type fingerprint which considers assessment of 307 different substructures and is based on KlekotaRothFingerprinter [44] in CDK.</td></tr><tr><td>4.</td><td>Enhanced Fingerprint</td><td>An in-house developed improvised extended fingerprint which accounts for stereochemistryand charges on molecules.</td></tr></table> |
3bf9b71e0aa3eb7453c9334731f538561208fe06157daf1ebdbed2018e76d610.png | simple | <table><tr><td>Elution methods</td><td>Elution liquid-solid ratio (mL/g)</td><td>Elution time (h)</td><td>Elution capacity (Q, mg/g)</td></tr><tr><td>Soxhlet extraction</td><td>100</td><td>24</td><td>547</td></tr><tr><td>Ultrasonic extraction</td><td>40</td><td>1</td><td>815</td></tr><tr><td>Microwave-assisted extraction</td><td>40</td><td>5</td><td>326</td></tr></table> |
69bace85879b5011845885d1c9f125a31959ee7ec829bd06b24ce15afe82a9de.png | simple | <table><tr><td>Node</td><td>Description</td><td>Degree</td></tr><tr><td>UBC</td><td>ubiquitin C</td><td>739</td></tr><tr><td>EGFR</td><td>epidermal growth factor receptor</td><td>157</td></tr><tr><td>MDM2</td><td>MDM2 proto-oncogene</td><td>153</td></tr><tr><td>TP53</td><td>tumor protein p53</td><td>152</td></tr><tr><td>APP</td><td>amyloid beta precursor protein</td><td>149</td></tr><tr><td>HSP90AA1</td><td>heat shock protein 90 alpha family class A member 1</td><td>149</td></tr><tr><td>EP300</td><td>E1A binding protein p300</td><td>135</td></tr><tr><td>SUMO1</td><td>small ubiquitin-like modifier 1</td><td>130</td></tr><tr><td>GRB2</td><td>growth factor receptor bound protein 2</td><td>128</td></tr><tr><td>SRC</td><td>SRC proto-oncogene, non-receptor tyrosine kinase</td><td>126</td></tr><tr><td>CTNNB1</td><td>catenin beta 1</td><td>125</td></tr><tr><td>FN1</td><td>fibronectin 1</td><td>123</td></tr><tr><td>YWHAZ</td><td>tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta</td><td>122</td></tr><tr><td>ESR1</td><td>estrogen receptor 1</td><td>110</td></tr><tr><td>HSP90AB1</td><td>heat shock protein 90 alpha family class B member 1</td><td>107</td></tr><tr><td>HDAC1</td><td>histone deacetylase 1</td><td>100</td></tr><tr><td>AKT1</td><td>AKT serine/threonine kinase 1</td><td>96</td></tr><tr><td>AR</td><td>androgen receptor</td><td>92</td></tr><tr><td>MAPK1</td><td>mitogen-activated protein kinase 1</td><td>88</td></tr><tr><td>CUL7</td><td>cullin 7</td><td>87</td></tr><tr><td>MYC<sup>†</sup></td><td>v-myc avian myelocytomatosis viral oncogene homolog</td><td>87</td></tr></table> |
fed66e02c7a70363a6a2316d4f212ed53f79825c7dbbaf188cab31804af7c9f0.png | complex | <table><tr><td>Parameters</td><td>Con. (μg/mL)</td><td>Duodenum</td><td>Jejunum</td><td>Ileum</td><td>Colon</td></tr><tr><td rowspan="3">P<sub>eff</sub> × 10<sup>−3</sup></td><td>3</td><td>7.11 ± 3.68</td><td>8.72 ± 3.47</td><td>9.48 ± 2.91</td><td>10.3 ± 1.56</td></tr><tr><td>6</td><td>6.93 ± 3.01</td><td>9.52 ± 3.28</td><td>8.15 ± 3.82</td><td>10.8 ± 1.79</td></tr><tr><td>9</td><td>9.03 ± 1.35</td><td>10.5 ± 1.67</td><td>9.13 ± 2.63</td><td>8.57 ± 3.75</td></tr><tr><td rowspan="3">10 cm%ABS</td><td>3</td><td>4.76 ± 1.27</td><td>4.98 ± 2.46</td><td>5.62 ± 1.81</td><td>6.34 ± 1.63</td></tr><tr><td>6</td><td>4.69 ± 1.46</td><td>5.19 ± 1.44</td><td>5.34 ± 2.57</td><td>5.59 ± 2.34</td></tr><tr><td>9</td><td>4.75 ± 0.98</td><td>5.09 ± 1.45</td><td>5.46 ± 2.24</td><td>5.75 ± 1.86</td></tr><tr><td rowspan="3">K<sub>a</sub> × 10<sup>−2</sup></td><td>3</td><td>1.52 ± 0.41</td><td>2.08 ± 0.33</td><td>2.62 ± 0.17</td><td>1.27 ± 0.19</td></tr><tr><td>6</td><td>1.66 ± 0.23</td><td>2.12 ± 0.23</td><td>2.48 ± 0.45</td><td>1.03 ± 0.37</td></tr><tr><td>9</td><td>1.44 ± 0.58</td><td>2.03 ± 0.45</td><td>2.43 ± 0.74</td><td>1.19 ± 0.24</td></tr></table> |
2be180355fb505a223e32a7d5a314161ef04f4b3f2f6843078e4448407bbccf6.png | simple | <table><tr><td>Parameter</td><td>Body weight (g)</td><td>Food Intake (Kcal)</td><td>Glucose (mM)</td><td>Ketones (mM)</td><td>Seizure Susceptibility</td></tr><tr><td>Body weight (g)</td><td>1.000</td><td></td><td></td><td></td><td></td></tr><tr><td>Food Intake (Kcal)</td><td>0.488*</td><td>1.000</td><td></td><td></td><td></td></tr><tr><td>Glucose (mM)</td><td>0.509*</td><td>0.382*</td><td>1.000</td><td></td><td></td></tr><tr><td>Ketones (mM)</td><td>-0.379*</td><td>-0.379*</td><td>-0.429*</td><td>1.000</td><td></td></tr><tr><td>Seizure Susceptibility</td><td>0.512*</td><td>0.464*</td><td>0.616*</td><td>-0.510*</td><td>1.000</td></tr></table> |
1d1c83dfc92e883072680de696ecd3d68d01a17a65c70ea7fa88a0df459ba86c.png | complex | <table><tr><td>Application</td><td>(n) Total</td><td colspan="6">Dead larvae %</td></tr><tr><td>(Days)</td><td>(Larvae)</td><td>CX<sup>a</sup> (5.5 mg/L)</td><td>CX (5.5 mg/L)</td><td>CX<sup>a</sup> (11 mg/L)</td><td>CX (11 mg/L)</td><td>CX<sup>a</sup> (22 mg/L)</td><td>Control</td></tr><tr><td>0</td><td>625</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>3</td><td>625</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>24 ± 31,749</td></tr><tr><td>6</td><td>625</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>100 ± 0</td><td>9,3 ± 6,110</td></tr><tr><td>9</td><td>625</td><td>99,2 ± 1,789</td><td>99,2 ± 1,789</td><td>99,2 ± 1,789</td><td>100 ± 0</td><td>100 ± 0</td><td>0 ± 0</td></tr><tr><td>12</td><td>675</td><td>95,1 ± 1,789</td><td>96,6 ± 3,578</td><td>98,3 ± 2,191</td><td>100 ± 0</td><td>100 ± 0</td><td>3,2 ± 9,237</td></tr><tr><td>15</td><td>625</td><td>95,1 ± 2,191</td><td>94,2 ± 6,066</td><td>98,3 ± 3,578</td><td>100 ± 0</td><td>98 ± 2,828</td><td>2,6 ± 2,309</td></tr><tr><td>18</td><td>625</td><td>93,6 ± 4,561</td><td>95,2 ± 3,347</td><td>95,2 ± 4,382</td><td>99,2 ± 1,789</td><td>100 ± 0</td><td>0 ± 0</td></tr><tr><td>21</td><td>625</td><td>83,2 ± 7,155</td><td>87,2 ± 7,694</td><td>89,6 ± 2,109</td><td>96,8 ± 3,347</td><td>96 ± 0</td><td>0 ± 0</td></tr><tr><td>24</td><td>625</td><td>80 ± 4</td><td>89,6 ± 3,578</td><td>88 ± 2,828</td><td>96,8 ± 3,346</td><td>98 ± 2,828</td><td>0 ± 0</td></tr></table> |
c81796083e4202adbe73379e73a3e9f9023f649740ddc67cd10417705547e85d.png | complex | <table><tr><td>Comorbidity</td><td colspan="3">Prevalence</td></tr><tr><td>N = 14,005</td><td>(n)</td><td>(%)</td><td>95% CI</td></tr><tr><td>Mental health condition</td><td>5,401</td><td>38.6%</td><td>(37.8% to 39.4%)</td></tr><tr><td>Physical conditions:</td><td> </td><td> </td><td> </td></tr><tr><td>Myocardial infarction</td><td>174</td><td>1.2%</td><td>(1.1% to 1.4%)</td></tr><tr><td>Congestive heart disease</td><td>233</td><td>1.7%</td><td>(1.5% to 1.9%)</td></tr><tr><td>Chronic obstructive pulmonary disease</td><td>1,106</td><td>7.9%</td><td>(7.5% to 8.3%)</td></tr><tr><td>End stage renal disease</td><td>223</td><td>1.6%</td><td>(1.4% to 1.8%)</td></tr><tr><td>Peripheral vascular disease</td><td>72</td><td>0.5%</td><td>(0.4% to 0.6%)</td></tr><tr><td>Asthma</td><td>1,780</td><td>12.7%</td><td>(12.2% to 13.3%)</td></tr><tr><td>Diabetes</td><td>1,167</td><td>8.3%</td><td>(7.9% to 8.8%)</td></tr><tr><td>Hypertension</td><td>2,093</td><td>14.9%</td><td>(14.4% to 15.5%)</td></tr><tr><td>Stroke</td><td>173</td><td>1.2%</td><td>(1.1% to 1.4%)</td></tr><tr><td>At least one physical condition</td><td>4820</td><td>34.4%</td><td>(33.6% to 35.2%)</td></tr><tr><td>Physical-mental health multimorbidity</td><td>2,174</td><td>15.5%</td><td>(14.9% to16.1%)</td></tr><tr><td>Multimorbidity (at least two physical conditions)</td><td>1,508</td><td>10.8%</td><td>(10.3% to 11.3%)</td></tr></table> |
1b0e4c01963201545976c1acc93adb32df7b8a89643c960f37184f408411ffc1.png | complex | <table><tr><td></td><td colspan="2">Items</td></tr><tr><td>Variables</td><td>Glucose</td><td>HbA1c</td></tr><tr><td>PATIENT INFORMATION</td><td></td><td></td></tr><tr><td>Number of subjects</td><td>485</td><td>155</td></tr><tr><td>Sex</td><td></td><td></td></tr><tr><td> Female</td><td>187 (38.6)</td><td>54 (34.8)</td></tr><tr><td> Male</td><td>298 (61.4)</td><td>101 (65.2)</td></tr><tr><td>Age, years</td><td></td><td></td></tr><tr><td> 20–49</td><td>67 (13.8)</td><td>20 (12.9)</td></tr><tr><td> 50–59</td><td>103 (21.2)</td><td>33 (21.3)</td></tr><tr><td> 60–69</td><td>150 (31.0)</td><td>47 (30.3)</td></tr><tr><td> 70<</td><td>165 (34.0)</td><td>55 (35.5)</td></tr><tr><td>Medication</td><td></td><td></td></tr><tr><td> candesartan cilexetil</td><td>177 (36.5)</td><td>51 (32.9)</td></tr><tr><td> losartan potassium</td><td>78 (16.1)</td><td>35 (22.6)</td></tr><tr><td> olmesartan medoxomil</td><td>56 (11.5)</td><td>21 (13.5)</td></tr><tr><td> telmisartan</td><td>56 (11.5)</td><td>18 (11.6)</td></tr><tr><td> valsartan</td><td>118 (24.3)</td><td>30 (19.4)</td></tr><tr><td>DATA INFORMATION</td><td></td><td></td></tr><tr><td>Number of examinations</td><td>2464</td><td>457</td></tr><tr><td>Treatment duration</td><td></td><td></td></tr><tr><td> 0 = "Baseline"</td><td>733 (29.8)</td><td>150 (32.8)</td></tr><tr><td> 1 = "~3 M"</td><td>1068 (43.3)</td><td>132 (28.9)</td></tr><tr><td> 2 = "3~6 M"</td><td>377 (15.3)</td><td>89 (19.5)</td></tr><tr><td> 3 = "6~12 M"</td><td>286 (11.6)</td><td>86 (18.8)</td></tr></table> |
c3be852f038c75982898d078156408d8c9f7c9cd5f4140be8cecf2093d6af100.png | simple | <table><tr><td>Phytochemical</td><td>Detection system</td><td>Observation</td><td>Result</td></tr><tr><td>Coumarin</td><td>365 nm</td><td>Blue spot</td><td>+</td></tr><tr><td>Flavonoids</td><td>5% AlCl<sub>3</sub></td><td>Yellow spot</td><td>+</td></tr><tr><td>Tannin</td><td>2% FeCl<sub>3</sub></td><td>Greenish Black spot</td><td>+</td></tr><tr><td>Saponin</td><td>10% Vanillin (Ethanol)</td><td>Violet and yellow</td><td>+</td></tr><tr><td>Monoterpene alcohol, Bitter principle saponin</td><td>Vanillin-H<sub>2</sub>SO<sub>4</sub></td><td>Blue</td><td>+</td></tr><tr><td>Triterpene and steroid</td><td>Lieberman-Buchard’s reagent</td><td>Brown and yellow spots</td><td>+</td></tr></table> |
54ab3663769fc289e34ac9f22da269a00b9d203dac85a08a177558c13223c4bc.png | complex | <table><tr><td colspan="3">Classification result</td></tr><tr><td rowspan="2">Actual result</td><td colspan="2"> Forecast result</td></tr><tr><td>P</td><td>N</td></tr><tr><td>P</td><td>TP</td><td>FN</td></tr><tr><td>N</td><td>FP</td><td>TN</td></tr></table> |
cf463e8d95042abbc4aa069af36cb42b23f6d9ea95f612f216d5b3d592a41ca8.png | complex | <table><tr><td rowspan="2">Time</td><td rowspan="2">Predicted value</td><td colspan="2">95% prediction intervals</td></tr><tr><td>Lower prediction limit</td><td>Upper prediction limit</td></tr><tr><td>2013m1</td><td>24.68</td><td>17.4</td><td>31.96</td></tr><tr><td>2013m2</td><td>22.05</td><td>14.60</td><td>29.49</td></tr><tr><td>2013m3</td><td>23.69</td><td>16.08</td><td>31.29</td></tr><tr><td>2013m4</td><td>23.35</td><td>15.59</td><td>31.12</td></tr><tr><td>2013m5</td><td>23.89</td><td>15.97</td><td>31.81</td></tr><tr><td>2013m6</td><td>23.43</td><td>15.35</td><td>31.50</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.